buserelin has been researched along with goserelin in 345 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 162 (46.96) | 18.7374 |
| 1990's | 168 (48.70) | 18.2507 |
| 2000's | 8 (2.32) | 29.6817 |
| 2010's | 6 (1.74) | 24.3611 |
| 2020's | 1 (0.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cantwell, BM; Carmichael, J; Harris, AL; Lind, MJ; Millward, MJ; Proctor, M; Robinson, A; Simmons, D | 1 |
| Diedrich, K; Naether, O | 1 |
| Beard, RW; Gangar, KF; Reid, BA | 1 |
| Dondi, D; Limonta, P; Maggi, R; Moretti, RM; Motta, M | 1 |
| Gangar, KF; Reid, BA | 1 |
| Brower, ST; Hollander, VP; Redding, TW; Schally, AV | 1 |
| Bajor, T; Balogh, A; Bökönyi, G; Horváth, A; Horváth, J; Kéri, G; Mezö, I; Teplán, I; Vadász, Z; Vántus, T | 1 |
| Debruyne, FM; Fernandez del Moral, P; Mulders, PF; Oosterhof, GO; Theeuwes, AG; van Berkel, HT | 1 |
| Matzkin, H; Soloway, MS | 1 |
| Carlström, K; Hasenson, M; Lundh, B; Pousette, A; Stege, R; Tribukait, B | 1 |
| Bennett, MK; Clayton, RN; Cox, BS; Craven, R; Furr, BJ; Grocock, CA; Harrison, CJ; O'Shaughnessy, PJ; Porter-Goff, AE; Scott, IS | 1 |
| Shaw, RW | 6 |
| Arkell, DG; Blackledge, GR; Dunn, JA; Emtage, LA; Lynch, TH; Wallace, DM; Waymont, B | 1 |
| Kennealey, GT; Vogelzang, NJ | 1 |
| Deichert, U; Duda, V; Gesenhues, T; Hackenberg, R; Schmidt-Rhode, P; Schulz, KD | 1 |
| Bocciolone, L; Bolis, G; Colombo, A; Rognoni, MT; Vendola, N; Vercellini, P | 1 |
| Bianco, AR; Blamey, RW; Jonat, W; Kaufmann, M; Namer, M | 1 |
| Coombes, RC; Dowsett, M; Stein, RC | 1 |
| Almond, GW; Esbenshade, KL; Richards, RG; Smith, CA | 1 |
| Lemay, A; Maheux, R | 1 |
| Baird, DT; Lumsden, MA; West, CP | 2 |
| Clerckx, F; Donnez, J; Gillerot, S; Grandjean, P; Nisolle, M | 1 |
| Frank, RA; Miller, RM | 1 |
| Aakvaag, A; Johannessen, DC; Lien, EA; Lønning, PE | 1 |
| Hipkin, LJ | 1 |
| Bunce, C | 1 |
| Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF | 1 |
| Baird, DT; Hillier, H; Lumsden, MA; Sweeting, V; West, CP | 1 |
| Kéri, G; Nicholson, RI | 1 |
| Reichel, RP; Schweppe, KW | 1 |
| Bonadimani, B; Cappellazzo, F; Catalini, S; Militello, C; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Schmeller, N | 1 |
| D'Alberton, A; Ferrari, A; Maggi, R; Molteni, P; Motta, T; Vercellini, P | 1 |
| McClelland, HR; Quinn, AJ | 1 |
| Altchek, A | 1 |
| Artioli, R; Brambilla, C; Escobedo, A; Lechuga, MJ; Motta, M | 1 |
| Davies, JH; Dearnaley, DP; Gelister, JS; Shearer, RJ | 1 |
| Höfler, H; Lax, S; Pummer, K; Radner, H; Wandschneider, G | 1 |
| Blanchet, P; Friede, J; Lemay, A; Maheux, R; Pratt, X | 1 |
| Barnett, DB; Haider, Y | 1 |
| Dundas, GS; Porter, AT; Venner, PM | 1 |
| Armitage, TG; Cooper, EH; Denis, L; Newling, DW; Richards, BR; Robinson, MR; Smith, PH; Sylvester, R | 1 |
| Chodak, GW; Kellman, H; Silver, RI; Straus, FH; Vogelzang, NJ | 1 |
| Lukkarinen, O | 1 |
| Forti, G; Serio, M | 1 |
| Chrisp, P; Goa, KL | 1 |
| Schmidt, JD | 1 |
| Chaban, M; Denis, L; Mahler, C; Verhelst, J | 1 |
| Block, NL; Chodak, G; Gau, TC; Kennealey, G; Schellhammer, PF; Scott, M; Smith, JA; Soloway, MS; Vogelzang, NJ | 1 |
| Balbi, B; Lantero, S; Oddera, S; Ravazzoni, C; Rossi, GA | 1 |
| Caplan, RJ; Chodak, GW; Smith, JA; Soloway, M; Vogelzang, NJ | 1 |
| Dodin, S; Dumont, M; Lemay, A; Maheux, R; Turcot-Lemay, L | 1 |
| Bono, A; Carneiro de Moura, JL; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, D; Robinson, M; Smith, P; Sylvester, R | 1 |
| Burslem, RW; Critchlow, JD; Lieberman, BA; Matson, PL; Morroll, DR; Troup, SA | 1 |
| Coombes, RC; Ford, HT; Gazet, JC | 1 |
| al-Bussam, N; Citrin, DL; Gau, TC; Guinan, P; Kennealey, GT; Resnick, MI; Scott, M | 1 |
| Baldelli, S; Cellerino, R; Menichetti, ET; Miseria, S; Murer, B; Torresi, U; Tummarello, D | 1 |
| Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC | 1 |
| Chadwick, DJ; Gillatt, DA; Gingell, JC | 1 |
| Clarke, NW; George, NJ; McClure, J | 1 |
| De Sutter, P; Dhont, M; Vandekerckhove, D; Vanluchene, E | 1 |
| Kuber, W; Spona, J; Viehberger, G; Zeillinger, R | 1 |
| Griffiths, K; Kaisary, AV; Peeling, WB; Tyrrell, CJ | 1 |
| Artioli, R; Bonadonna, G; Brambilla, C; Escobedo, A; Lechuga, MJ; Motta, M | 1 |
| Bastert, G; Jonat, W; Kaufmann, M; Maass, H; Schachner-Wünschmann, E | 1 |
| Blamey, RW; Dixon, AR; Jackson, L; Nicholson, RI; Robertson, JF | 1 |
| Fischer, M; Flamm, J; Höltl, W; Pflüger, H; Tomschi, W | 1 |
| Tattersall, MH; Wilcken, N | 1 |
| Lauritzen, C; Rossmanith, WG; Sasse, V; Wirth, U | 2 |
| De Vroey, P; Impens, N; Laureys, M; Schandevyl, W; Slabbynck, H | 1 |
| Bakker, GH; de Jong, FH; Foekens, JA; Klijn, JG; Meijers, M; van Garderen-Hoetmer, A; Woutersen, RA | 1 |
| Cetera, C; de Laurentiis, G; Giorgino, FL | 1 |
| Cetera, C; Giorgino, FL | 1 |
| Hickling, DJ; Killick, SR | 1 |
| Taylor, TK | 1 |
| France, J; Holdaway, IM; Parr, CE | 1 |
| Blamey, RW; Bouzubar, N; Dixon, AR; Ellis, IO; McClelland, R; Nicholson, RI; Robertson, JF; Walker, KJ | 1 |
| Gateley, CA; Mansel, RE | 1 |
| Mettler, L; Schachner-Wünschmann, E; Steinmüller, H | 1 |
| Forsling, ML; Kelestimur, H; Windle, R | 1 |
| Altwein, JE; Boccardo, F; Haefliger, JM; Holdaway, IM; Jordaan, JP; Klippel, F; Lunglmayr, G; Tyrrell, CJ; Varenhorst, E | 1 |
| Lundmo, PI; Mjølnerød, OK; Samdal, F; Vada, K | 1 |
| Horlbeck, R; Jurincic, CD; Klippel, KF | 1 |
| Cucuccio, S; De Cecco, L; Leone, M; Messeni Leone, M; Valenzano-Menada, M; Venturini, PL | 1 |
| Berná, L; Blanco, R; Carrió, I; Estorch, M; Germá, JR; Torres, G | 1 |
| Brideau, NA; Dodin, S; Forest, JC; Lemay, A; Maheux, R | 1 |
| Okuda, KJ; Thomas, EJ; Thomas, NM | 1 |
| Denis, L | 2 |
| Irvine, CH; Turner, JE | 1 |
| Bianco, AR; Calabresi, F; De Placido, S; Fiorentino, M; Fosser, V; Lenti, R; Lopez, M; Perrone, F; Rosso, R; Sismondi, PG | 1 |
| Anderson, H; Dodwell, DJ; Howell, A | 1 |
| Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR | 2 |
| Furr, BJ; Morris, ID; Robinson, J; Shalet, SM; Ward, JA | 1 |
| Deichert, U; Duda, V; Gesenhues, T; Hackenberg, R; Schulz, KD; Sturm, G | 1 |
| Ahmann, FR; Caplan, R; Gau, T; Kreis, W; Lesser, M; Scott, M; Vinciguerra, V | 1 |
| Firichenko, VI; Vasil'chenko, NP | 1 |
| Blom, P; Johansen, TE; Kjellevold, K; Ogreid, P | 1 |
| Andersen, AN; Klarskov, P; Trokmar, M | 1 |
| Ayub, M; Levell, MJ | 1 |
| Ding, YQ; Huhtaniemi, I; Jaakkola, T; Kellokumpu-Lehtinen, P; Martikainen, H; Rönnberg, L; Tapanainen, J; Valavaara, R | 1 |
| Eechaute, W; Lacroix, E; Vanderstichele, H | 1 |
| Blackledge, GR; Boughton, BJ; Emtage, LA; George, J; Trethowan, C | 1 |
| Bouzubar, N; Davies, P; Gee, JM; Nicholson, RI; Rushmere, NK; Walker, KJ; Wills, RJ | 1 |
| Anserini, P; Costantini, S; De Cecco, L; Remorgida, V; Valenzano, M; Venturini, PL | 1 |
| Caleffi, M; Chaudary, MA; Fentiman, IS; Hamed, H | 1 |
| Gez, E; Kovner, F | 1 |
| Armitage, TG; Bono, A; Calais da Silva, F; Debruyne, F; Denis, L; Robinson, P; Smith, PH; Sylvester, R | 1 |
| De Pauw, M; Denis, L; Newling, DW; Robinson, MR; Sylvester, R | 1 |
| Christensen, I; Denis, L; Iversen, P; Suciu, S; Sylvester, R | 2 |
| Bond, A; Carvalho, AP; De Pauw, M; Denis, L; Keuppens, F; Newling, D; Ongena, P; Smith, P; Sylvester, R; Vermeylen, K | 1 |
| Christensen, MG; Friis, E; Hornbøl, P; Hvidt, V; Iversen, HG; Iversen, P; Klarskov, P; Krarup, T; Lund, F; Mogensen, P | 1 |
| Schulze, H; Senge, T | 1 |
| Bono, A; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, D; Pinto de Carvalho, AP; Robinson, M; Smith, P; Sylvester, R | 1 |
| D'Eramo, G; Di Silverio, F; Sciarra, F | 1 |
| Barbieri, RL; Friedman, AJ; Lobel, SM; Rein, MS | 1 |
| Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC | 1 |
| Dowsett, M; Edmonds, DK; Maouris, P; Robertson, WR; Rose, G; Rothwell, C | 1 |
| Klarskov, P; Lund, F; Petersen, SE | 1 |
| Distler, W; von Matthiessen, H | 1 |
| Eidtmann, H; Jonat, W; Kügler, G; Kunz, T; Maass, H | 1 |
| Andrén-Sandberg, A | 1 |
| Elstein, M; Golland, IM; Laing, I; Shalet, SM; Vaughan-Williams, CA | 1 |
| Hwang, YS; John, MJ; Krall, JM; McGowan, D; Perez, CA; Pilepich, MV | 1 |
| Blamey, RW; Dixon, AR; Jackson, L; Nicholson, RI; Robertson, JF; Walker, KJ | 1 |
| Fitzpatrick, FT; Greenstein, BD; Hamblin, A; Kendall, MD; Khoylou, F; Safieh, B | 1 |
| Anserini, P; Costantini, S; Cucuccio, S; de Cecco, L; Fasce, V; Venturini, PL | 1 |
| Coyle, J; Fisher, B; Gunduz, N; Rudock, C; Saffer, E | 2 |
| Girsch, E; Kratzik, C; Kuber, W; Spona, J; Treu, T; Zeillinger, R | 1 |
| Arcaini, L; Bianchi, S; Candiani, GB; Candiani, M; Fedele, L; Vercellini, P | 1 |
| Debruyne, FM; del Moral, PF; Delaere, KP; Dijkman, GA; Furr, BJ; Hutchinson, FJ; Kums, JJ; Plasman, JW | 1 |
| Bono, A; De Moura, JL; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, D; Robinson, M; Smith, P; Sylvester, R | 1 |
| Blamey, RW; Dixon, A; McClelland, RA; Nicholson, RI; Robertson, JF; Walker, KJ | 1 |
| Barrada, M; Baur, M; Dittrich, C; Fitz, R; Sevelda, P; Vavra, N | 1 |
| Di Silverio, F; Serio, M | 1 |
| Bassi, F; Serio, M | 1 |
| Cortese, P; Defabiani, E; Giai, M; Sismondi, P | 1 |
| Guidez, C | 1 |
| Debruyne, FM; Dijkman, GA; Fernandez del Moral, P; Furr, BJ; Hutchinson, FG; Plasman, JW; Pull, HC; van der Meijden, AP | 1 |
| Moffat, LE | 1 |
| Lunglmayr, G | 2 |
| Bono, A; De Moura, JL; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, DW; Robinson, M; Smith, PH; Sylvester, R | 1 |
| Iversen, P | 1 |
| Cariou, G; Coloby, P; Colombel, P; Coulange, C; Fourcade, RO; Grise, P; Mangin, P; Poterre, M; Soret, JY | 1 |
| Boccardo, F; Cortellini, P; Decensi, A; Delli Ponti, U; Giuliani, L; Guarneri, D; Martorana, G; Oneto, F; Petracco, S; Rubagotti, A | 1 |
| D'Eramo, G; Di Silverio, F; Sciarra, F; Serio, M | 1 |
| Cooper, EH; Denis, L; Hetherington, JW; Newling, DW; Richards, B; Robinson, MR; Siddall, JK | 1 |
| Ikemoto, I; Machida, T | 1 |
| Blackledge, GR; Emtage, LA; Lewis, PW | 1 |
| Costantini, A; De Bellis, A; Fiorelli, G; Longo, A; Natali, A; Serio, M | 1 |
| Browning, D; Cooke, ID; Ledger, WL; Lenton, EA; Thomas, EJ | 1 |
| Diechert, U; Duda, V; Gesenhues, T; Hackenberg, R; Schulz, KD; Sturm, G | 1 |
| Chodak, GW | 1 |
| Peeling, WB | 2 |
| Cassileth, BR; Hait, HI; Kennealey, GT; Schellhammer, PS; Seidmon, EJ; Soloway, MS; Vogelzang, NJ | 1 |
| Blamey, RW; Griffiths, K; Nicholson, RI; Robertson, JF; Turkes, A; Walker, KJ; Walker, RF | 1 |
| de Jong, FH; Lamberts, SW; Reubi, JC; Uitterlinden, P | 1 |
| Steg, A | 1 |
| Ataya, K; Ramahi, A; Tadros, M | 1 |
| Gardner, RL; Shaw, RW | 1 |
| Baird, DT; Bramley, TA; Hawkins, RA; Lumsden, MA; Rumgay, L; West, CP | 1 |
| Albrecht, M; Eiermann, W; Hilfrich, J; Jänicke, F; Jonat, W; Kaufmann, M; Kleeberg, U; Kreienberg, R; Schmid, H; Weitzel, HK | 1 |
| Cantwell, BM; Carmichael, J; Dowsett, M; Harris, AL | 2 |
| Bakker, GH; De Jong, FH; Foekens, JA; Klijn, JG; Portengen, H; Setyono-Han, B | 1 |
| Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA | 1 |
| Bono, A; Carvalho, AP; de Moura, JL; De Pauw, M; Denis, L; Newling, D; Ongena, P; Smith, P; Sylvester, R | 1 |
| Arkell, D; Blacklock, R; Emtage, LA; Hay, A; Hughes, M; Jones, M; Kelly, K; Rouse, A; Trethowan, C; Wallace, DM | 1 |
| Irie, S; Matsumura, Y; Nagai, A; Nanba, K; Ohashi, T; Ohashi, Y; Ohmori, H; Tanahashi, T; Yamashita, Y | 1 |
| Hansen, JB; Hansen, RI; Hvidt, V; Iversen, HG; Iversen, P; Mogensen, P; Pedersen, T; Rose, C; Stage, JG | 1 |
| Kaufmann, M; Schachner-Wünschmann, E; Schmid, H | 1 |
| Kang, IS; Kuehl, TJ; Siler-Khodr, TM | 1 |
| Baird, DT; Hillier, H; Lumsden, MA; West, CP | 1 |
| Huhtaniemi, I; Kauppila, A; Martikainen, H; Penttinen, J | 1 |
| Nicholson, RI; Walker, KJ | 2 |
| Griffiths, K; Turkes, AO | 1 |
| Blamey, RW; Nicholson, RI; Robertson, JF; Walker, KJ | 2 |
| Ataya, KM; Blacker, CM; Latif, ZA; Mutchnick, MG; Sakr, W | 1 |
| Ceda, GP; Ceresini, G; Cortellini, P; Denti, L; Hoffman, AR; Valenti, G | 1 |
| Fieggan, AG; Pienaar, CA; Van der Spuy, ZM; Wood, MJ | 1 |
| Baird, DT; Bramley, TA; Hawkins, TA; Lumsden, MA; West, CP | 1 |
| Crook, D; Gardner, R; Nolan, J; Shaw, RW; Stevenson, JC; Worthington, M | 1 |
| Gardner, R; Lees, B; Shaw, RW; Stevenson, JC | 1 |
| Blamey, RW; Nicholson, RI; Read, GF; Robertson, JF; Turkes, A; Walker, KJ; Walker, RF | 1 |
| Kaufmann, M | 1 |
| Cantwell, BM; Dowsett, M; Harris, AL | 1 |
| Tyrrell, C | 1 |
| Abeloff, M; Dalton, WS; Osborne, CK; Robert, NJ | 1 |
| Jonat, W | 1 |
| Debruyne, F | 1 |
| Furr, BJ | 1 |
| Lemay, A | 2 |
| Cheson, BD | 1 |
| Mansel, RE | 1 |
| Emons, G; Hammar, M; Petersson, F | 1 |
| Astone, A; Barone, C; Cassano, A; Garufi, C; Noviello, MR; Pietrantonio, F | 1 |
| Dowsett, M; Edmonds, DK; Maouris, P; Rose, G | 1 |
| Groszmann, RJ; Kaumann, AJ | 1 |
| de Jong, FH; Lamberts, SW; Uitterlinden, P | 1 |
| Brahams, D | 1 |
| Britt, JH; Esbenshade, KL | 1 |
| Blamey, RW; Dyas, J; Nicholson, RI; Plowman, PN; Turkes, A; Walker, KJ; Williams, M | 1 |
| Eisenberger, MA; Friedman, MA; O'Dwyer, PJ | 1 |
| Hjertberg, H; Malmqvist, E; Svensson, M; Varenhorst, E | 1 |
| Bolton, C; Gingell, JC; Hartog, M; Kadow, C; Paisey, RB | 1 |
| Blamey, RW; Nicholson, RI; Turkes, A; Walker, KJ; Williams, MR | 2 |
| Kotake, T; Sonoda, T; Usami, M | 1 |
| Guémené, D; Williams, JB | 1 |
| Andrianne, R; Bouffioux, C; de Leval, J; Désirotte, J; Doupagne, M; Focan, C; Franchimont, P | 1 |
| Arkell, DG; Bailey, LC; Blackledge, G; Clayton, RN; Cottam, J; Farrar, D; Holder, G; Lynch, SS; Perren, TJ; Young, CH | 1 |
| Bouffioux, C; de Leval, J; Denis, L; Mahler, C | 2 |
| Ahmed, SR; Blacklock, NJ; Costello, CB; Grant, JB; Howell, A; Shalet, SM; Weatherson, T | 1 |
| Ahmed, SR; Blacklock, NJ; Costello, CB; Grant, JB; Howell, A; Shalet, SM | 1 |
| Opsomer, RJ; Van Cangh, PJ | 1 |
| Nicholson, RI; Plowman, PN; Walker, KJ | 1 |
| Cooke, ID; Jenkins, J; Lenton, EA; Thomas, EJ | 1 |
| Beck, JL; Herman, CJ; Rolland, R; Thomas, CM; van Kroonenburgh, MJ; Vemer, HM | 1 |
| Chin, JL; deHaan, HA; Greco, JM; Huben, RP; Murphy, GP; Scott, M | 1 |
| Fitzpatrick, FT; Greenstein, BD; Kendall, MD; Wheeler, MJ | 1 |
| Calle Fernández, JR; Rubio Herrera, MA | 1 |
| Aso, Y; Ishigami, J; Itatani, H; Kotake, T; Matsuda, M; Ohi, Y; Ohkawa, T; Okajima, E; Osafune, M; Usami, M | 1 |
| Hallett, KG; Seddon, A; Spencer, GS | 1 |
| Kotake, T; Matsuda, M; Okajima, E; Osafune, M; Sonoda, T; Usami, M | 1 |
| Blamey, RW; Robertson, JF | 1 |
| Ahmann, FR; Citrin, DL; deHaan, HA; Guinan, P; Jordan, VC; Kreis, W; Scott, M; Trump, DL | 1 |
| Beacock, CJ; Buck, AC; Griffiths, K; Peeling, WB; Rees, RW; Turkes, A; Walker, K; Zwinck, R | 1 |
| Baird, DT; Lawson, S; Lumsden, MA; West, CP; Williamson, J | 1 |
| Beck, JL; Herman, CJ; Rolland, R; van Daal, WA; van Kroonenburgh, MJ; Vemer, HM | 1 |
| Debruyne, FM; Denis, L; Keuppens, F; Lunglmayr, G; Mahler, C; Newling, D; Richards, B; Robinson, MR; Smith, PH; Weil, EH | 1 |
| Claes, HI; Vandenbussche, L; Vereecken, RL | 1 |
| Alcini, E; D'Addessi, A; Vacilotto, D | 1 |
| Albano, D; Bianco, A; Bolgan, A; Bono, AV; Frugoni, A; Morelli, A; Pozzi, E; Usai, E | 1 |
| Newling, DW | 1 |
| Baird, DT; West, CP | 1 |
| Greco, J; Huben, R; Murphy, GP | 1 |
| Matsumoto, K; Nakamura, M; Namiki, M; Nishimune, Y; Nonomura, N; Okuyama, A; Sonoda, T | 1 |
| Allen, WR; Crowhurst, JS; Ellis, DR; Greenwood, RE; Rossdale, PD; Sanderson, MW; Simpson, DJ | 1 |
| Hjertberg, H; Kågedal, B; Nordenskjöld, B; Svensson, M; Varenhorst, E | 2 |
| de Voogt, HJ; Geldof, AA; Rao, BR | 1 |
| Burford, GD; Matta, WH; Shaw, RW | 1 |
| Griffiths, K; Peeling, WB; Turkes, AO | 1 |
| Arkell, DG; Blackledge, GR; Cottam, J; Emtage, LA; Farrar, D; Hughes, MA; Perren, TJ; Stuart, NS; Wallace, DM; Young, CH | 1 |
| Arnold, AJ; Desmond, AD | 1 |
| Cantwell, B; Dowsett, M; Harris, AL; Jeffcoate, SL; Lal, A | 1 |
| Hammar, M; Hjertberg, H; Mathson, K; Petersson, F; Varenhorst, E | 1 |
| Aaronson, N; Da Silva, FC | 1 |
| Debruyne, FM; Fernandez del Moral, P; Geboers, AD | 1 |
| Griffiths, K; Kaisary, AV; Peeling, WB; Ryan, PG; Turkes, A | 1 |
| Boulton, J; Croxson, MS; Harvey, V; Holdaway, IM; Ibbertson, HK; Knox, BS; List, A; Rutland, M | 1 |
| Akaza, H; Araki, T; Aso, Y; Isurugi, K; Kotake, T; Matsuda, M; Niijima, T; Okajima, E; Osafune, M; Usami, M | 1 |
| Castillo, RJ; Knight, PG | 1 |
| Blamey, RW; Ellis, IO; Elston, CW; Nicholson, RI; Robertson, JF; Williamson, K | 1 |
| Dyer, C | 1 |
| Debruyne, FM; Fernandez del Moral, P; Litjens, TT; Weil, EH | 1 |
| Debruyne, FM; Denis, L; Lunglmayer, G; Mahler, C; Newling, DW; Richards, B; Robinson, MR; Smith, PH; Weil, EH; Whelan, P | 1 |
| Bieglmayer, C; Girsch, E; Lunglmayr, G; Meixner, EM; Viehberger, G | 1 |
| Cirulli, C; Drago, JR; Nesbitt, JA | 1 |
| Javadpour, N | 1 |
| Kontturi, M; Lukkarinen, O | 1 |
| Kaldenhoff, H; Schulze, H; Senge, T | 1 |
| Harvengt, C | 1 |
| Koiter, TR; Moes, H; Schuiling, GA | 1 |
| Ahmann, FR; de Haan, H; Jordan, VC; Kreis, W; Scott, M | 1 |
| Ataya, KM; Blacker, CM; Moghissi, KS; Mohammad, SH; Palmer, KC | 1 |
| Bouffioux, C | 1 |
| Kaufmann, M; Kiesel, L; Klinga, K; Schmid, H | 1 |
| Baird, DT; Bramley, T; Lumsden, MA; Rumgay, L; West, CP | 1 |
| Budman, DR; Delli Bovi, P; Kreis, W; Vinciguerra, V | 1 |
| Akaza, H; Araki, T; Aso, Y; Itatani, H; Kotake, T; Matsuda, M; Nihsijima, T; Okajima, E; Osafune, M; Usami, M | 1 |
| Akaza, H; Isurugi, K; Kotake, T; Matsuda, M; Okajima, E; Osafune, M; Saitoh, Y; Sonoda, T; Usami, M | 1 |
| Adenis, L; Audhuy, B; Bugat, R; Colombel, P; Couette, JE; Grise, P; Khater, R; LePorz, B; Metz, R; Namer, M | 1 |
| Beacock, CJ | 1 |
| Bonichon, F; Coste, P; Lamarche, P; Mage, P; Mauriac, L; Richaud, P | 1 |
| Alcini, E; D'Addessi, A; Destito, A; Grasso, G | 1 |
| Boulton, J; Croxson, MS; Harvey, V; Holdaway, IM; Ibbertson, HK; Knox, BS | 1 |
| Denis, L; Mahler, C | 1 |
| Peeling, WB; Ryan, PG | 1 |
| Blackledge, GR; Emtage, LA; Hilton, C; Kelly, K; Trethowan, C | 1 |
| Akaza, H; Araki, T; Aso, Y; Itatani, H; Kotake, T; Matsuda, M; Niijima, T; Okajima, E; Osafune, M; Usami, M | 1 |
| Ahmed, SR; Blacklock, NJ; Chowdhury, SD; Grant, J; Howell, A; Shalet, SM; Weatherson, T | 1 |
| Arkell, D; Bailey, LC; Blackledge, GR; Clayton, RN; Cottam, J; Perren, TJ | 1 |
| Denis, L; Lunglmayr, G; Mahler, C; Robinson, MR; Stitch, R; Walker, K | 1 |
| Furr, BJ; Hutchinson, FG | 2 |
| Sharpe, RM | 1 |
| Bloom, SR; Kerle, DJ; Roe, SM; Williams, G; Yeo, T | 1 |
| Griffiths, K; Harper, ME; Peeling, WB; Pierrepoint, CG; Turkes, AO; Walker, KJ; Wilson, DW | 1 |
| Ahmed, SR; Blacklock, NJ; Grant, J; Howell, A; Shalet, SM | 1 |
| de Jong, FH; Romijn, JC; Schröder, FH; van Steenbrugge, GJ | 1 |
| Beacock, C; Buck, AC; Griffiths, K; Peeling, WB; Turkes, A; Turkes, AO; Walker, KJ; Zwink, R | 1 |
| Bloom, SR; Dunlop, H; Griffin, S; Kerle, D; Williams, G | 1 |
| Allen, JM; Bloom, SR; Kerle, D; O'Shea, JP; Smith, C; Williams, G; Yeo, T | 1 |
| Allen, J; Bloom, SR; Doble, A; Kerle, D; Ware, H; Williams, G | 1 |
| Abdurazak, N; Cheng, WC; Lee, FY; Oyesanya, OA; Quah, E; Teo, SK | 1 |
| Healy, DL | 1 |
| Van Leusden, HA | 1 |
| Dondi, D; Garattini, E; Limonta, P; Marelli, MM; Moretti, RM; Motta, M | 1 |
| Hovatta, O; Juntunen, K; Martikainen, H; Ratsula, K; Tapanainen, J; Tulppala, M; Tuomivaara, L | 1 |
| Hovatta, O; Tapanainen, JS | 1 |
| Black, CM; Jacobs, HS; Ostlere, LS; Rustin, MH; Stevens, HP | 1 |
| Arnone, R; Capelli, M; Cognigni, G; Dellai, P; Falbo, A; Filicori, M; Flamigni, C | 1 |
| Shaw, RW; Waller, KG | 1 |
| Gilliland, GB; Seeras, RC | 1 |
| Bühler, K; Gärtner, A; Kuhlmann, M; Regidor, PA; Schindler, AE; Schindler, EM | 1 |
| Amama, EA; Minaguchi, H; Taga, M | 1 |
| de Voogt, H; Denis, L; Sylvester, RJ | 1 |
| Beijnen, JH; Boschma, MU; Bult, A; Hoitink, MA; Underberg, WJ; van der Houwen, OA; Wiese, G | 1 |
| Cook, T; Sheridan, WP | 1 |
| Davidson, NE | 1 |
| Blamey, RW; Boccardo, F; Duchateau, L; Klijn, JG; Sylvester, R; Tominaga, T | 1 |
| Ayabe, T | 1 |
| Noguchi, S; Taguchi, T | 1 |
| Boĭko, AV; Bychkova, NM; Dar'ialova, SL; Novikova, OV | 1 |
| Amini, A; Lodén, H | 1 |
| Cheon, KW; Choi, BC; Lee, HB; Lee, SC; Song, SJ; Yoo, KJ; Yu, SY | 1 |
| Furui, T; Imai, A; Suzuki, N; Yamamoto, A | 1 |
| Carsi, M; Iannazzo, S; Perachino, M; Pradelli, L | 1 |
| Almeling, S; Holzgrabe, U; Nap, CJ | 1 |
| Hamm, J; Morris, WJ; Pickles, T; Schreiber, WE; Tyldesley, S | 1 |
| Anikus'ko, NF; Liubota, II; Liubota, RV; Shchepotin, IB; Zotov, AS | 1 |
| Cicione, A; De Nunzio, C; Franco, A; Gravina, C; Grimaldi, MC; Guercio, A; Lombardo, R; Nacchia, A; Tema, G; Tubaro, A | 1 |
27 review(s) available for buserelin and goserelin
| Article | Year |
|---|---|
Recent developments in endocrine treatment of prostate cancer.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Prostatic Neoplasms; Tosyl Compounds | 1992 |
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogens; Female; Goserelin; Humans; Menopause | 1992 |
Goserelin (Zoladex) in the treatment of fibroids.
Topics: Buserelin; Combined Modality Therapy; Drug Therapy, Combination; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estradiol; Tamoxifen; Uterine Neoplasms | 1992 |
Zoladex (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy.
Topics: Buserelin; Endometriosis; Female; Goserelin; Humans; Leiomyoma; Uterine Neoplasms | 1992 |
The induction of amenorrhoea.
Topics: Amenorrhea; Buserelin; Contraceptives, Oral; Danazol; Female; Gestrinone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Military Personnel | 1992 |
Management of fibroids.
Topics: Buserelin; Female; Goserelin; Humans; Hysteroscopy; Leiomyoma; Leuprolide; Methods; Uterine Neoplasms | 1992 |
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.
Topics: Animals; Breast Neoplasms; Buserelin; Drug Evaluation; Endometriosis; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Gonadotropins; Goserelin; Humans; Leiomyoma; Male; Menstruation Disturbances; Polycystic Ovary Syndrome; Prostatic Neoplasms; Uterine Neoplasms | 1991 |
Endocrine therapy for desmoid tumors.
Topics: Adult; Buserelin; Female; Fibroma; Goserelin; Humans; Intestinal Neoplasms; Intestine, Small; Leg; Tamoxifen | 1991 |
Endocrine therapy for advanced stage D prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Estradiol Congeners; Goserelin; Humans; Leuprolide; Male; Orchiectomy; Prostatic Neoplasms | 1991 |
New endocrine approaches to breast cancer.
Topics: Androgen Antagonists; Animals; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteolytic Agents; Progestins; Rats; Somatostatin; Triptorelin Pamoate | 1990 |
[Treatment of patients with uterine myoma and its effectiveness].
Topics: Adult; Buserelin; Drug Evaluation; Female; Goserelin; Humans; Hysterectomy; Leiomyoma; Middle Aged; Uterine Neoplasms | 1990 |
[Luteinizing hormone-releasing hormone agonists for treatment of breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans | 1990 |
New trends in the endocrine treatment of breast cancer.
Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
[Treatment with the LH-RH agonist (Zoladex depot) in patients with puberty praecox].
Topics: Buserelin; Delayed-Action Preparations; Goserelin; Humans; Puberty, Precocious | 1990 |
[Zoladex in the treatment of mammary carcinoma].
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Buserelin; Goserelin; Humans; Mammary Neoplasms, Experimental | 1990 |
Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma.
Topics: Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms | 1989 |
Gn-RH agonists in breast and gynaecologic cancer treatment.
Topics: Animals; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Genital Neoplasms, Female; Goserelin; Humans; Luteinizing Hormone; Menopause; Rats; Rats, Inbred Strains | 1989 |
Endocrine treatment of prostate cancer.
Topics: Androgen Antagonists; Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1989 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Endocrine factors in the treatment of prostatic cancer.
Topics: Buserelin; Castration; Chorionic Gonadotropin; Cosyntropin; Dexamethasone; Diethylstilbestrol; Estrogens; Goserelin; Hormones; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1985 |
Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose.
Topics: Buserelin; Dose-Response Relationship, Drug; Drug Delivery Systems; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Leuprolide; Menstrual Cycle; Nafarelin; Structure-Activity Relationship; Triptorelin Pamoate | 1994 |
Pituitary down-regulation with goserelin (Zoladex) for in vitro fertilisation.
Topics: Buserelin; Delayed-Action Preparations; Down-Regulation; Female; Fertilization in Vitro; Goserelin; Humans; Ovulation Induction; Pituitary Gland; Randomized Controlled Trials as Topic; Treatment Outcome | 1994 |
Development of GnRH antagonists for prostate cancer: new approaches to treatment.
Topics: Antineoplastic Agents, Hormonal; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Testosterone | 2000 |
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Premenopause; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 2001 |
[An outline of GnRH analogue].
Topics: Animals; Buserelin; Drug Design; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Phenylurea Compounds; Pyrimidinones; Thymine | 2006 |
[Clinical applications of GnRHa in breast cancer].
Topics: Breast Neoplasms; Buserelin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Ovariectomy; Randomized Controlled Trials as Topic; Tamoxifen | 2006 |
Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy.
Topics: Aged; Antineoplastic Agents, Hormonal; Buserelin; Cost-Benefit Analysis; Decision Trees; Drug Costs; Gonadotropin-Releasing Hormone; Goserelin; Humans; Italy; Leuprolide; Male; Models, Econometric; Proportional Hazards Models; Prostatic Neoplasms; Survival Analysis; Triptorelin Pamoate | 2011 |
91 trial(s) available for buserelin and goserelin
| Article | Year |
|---|---|
A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer.
Topics: Adult; Aged; Buserelin; Drug Evaluation; Female; Goserelin; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms | 1992 |
An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.
Topics: Adolescent; Adult; Buserelin; Danazol; Delayed-Action Preparations; Endometriosis; Female; Goserelin; Humans; Menstruation; Pregnancy | 1992 |
Phase III randomised study of zoladex versus stilboestrol in the treatment of advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Buserelin; Diethylstilbestrol; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Time Factors; Treatment Outcome | 1992 |
Goserelin depot in the treatment of premenopausal advanced breast cancer.
Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Goserelin; Humans; Luteinizing Hormone; Menopause; Menstruation; Middle Aged | 1992 |
Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.
Topics: Adult; Buserelin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Uterine Neoplasms | 1992 |
Hormonal treatment of unresectable pancreatic cancer with LHRH analogue (goserelin).
Topics: Aged; Antigens, Tumor-Associated, Carbohydrate; Buserelin; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Goserelin; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Survival Analysis | 1992 |
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group.
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Testosterone | 1991 |
Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group.
Topics: Alkaline Phosphatase; Buserelin; Follow-Up Studies; Goserelin; Humans; Male; Multivariate Analysis; Orchiectomy; Pain; Prognosis; Prospective Studies; Prostatic Neoplasms; Survival Analysis; Testosterone | 1991 |
Total androgen ablation: European experience. The EORTC GU Group.
Topics: Aged; Buserelin; Flutamide; Goserelin; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms | 1991 |
Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study).
Topics: Adult; Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunohistochemistry; Middle Aged; Neoplasm Staging; Pilot Projects; Receptors, Estrogen | 1991 |
A comparison of Zoladex and DES in the treatment of advanced prostate cancer: results of a randomized, multicenter trial.
Topics: Aged; Antineoplastic Agents; Buserelin; Diethylstilbestrol; Drug Implants; Follow-Up Studies; Goserelin; Humans; Male; Prostatic Neoplasms | 1991 |
Primary systemic therapy for operable breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen | 1991 |
Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Buserelin; Goserelin; Humans; Ireland; Male; Orchiectomy; Prostatic Neoplasms; Survival Rate; Testosterone; United Kingdom | 1991 |
The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group.
Topics: Adult; Breast Neoplasms; Buserelin; Combined Modality Therapy; Delayed-Action Preparations; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Middle Aged; Neoplasm Metastasis | 1991 |
Complete androgen deprivation prior to radical prostatectomy in patients with stage T3 cancer of the prostate.
Topics: Aged; Buserelin; Combined Modality Therapy; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Pilot Projects; Preoperative Care; Prostatectomy; Prostatic Neoplasms; Time Factors | 1991 |
A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Drug Tolerance; Flutamide; Goserelin; Humans; Male; Prostatic Neoplasms; Remission Induction; Time Factors; United Kingdom | 1991 |
Combined treatment (goserelin plus flutamide) versus monotherapy (goserelin alone) in advanced prostate cancer: a randomized study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Remission Induction; Survival Rate | 1991 |
Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol.
Topics: Adult; Apolipoproteins; Buserelin; Cholesterol, HDL; Cholesterol, LDL; Danazol; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans | 1991 |
LH-RH analogue Zoladex in the treatment of pre- and perimenopausal women with metastatic breast cancer (results of the Italian Cooperative Study).
Topics: Adult; Breast Neoplasms; Buserelin; Chemotherapy, Adjuvant; Delayed-Action Preparations; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Life Tables; Luteinizing Hormone; Menopause; Middle Aged | 1991 |
Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis.
Topics: Buserelin; Chemistry, Pharmaceutical; Delayed-Action Preparations; Endocrine Glands; Endometriosis; Female; Goserelin; Humans; Multicenter Studies as Topic; Safety | 1990 |
Haemostatic changes during hormone manipulation in advanced prostate cancer: a comparison of DES 3 mg/day and goserelin 3.6 mg/month.
Topics: Aged; Aged, 80 and over; Antithrombin III; Buserelin; Diethylstilbestrol; Goserelin; Hemostasis; Humans; Male; Middle Aged; Prostatic Neoplasms | 1990 |
Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Buserelin; Chi-Square Distribution; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Leiomyoma; Luteinizing Hormone; Random Allocation; Ultrasonography; Uterine Neoplasms | 1990 |
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Radionuclide Imaging; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
Comparability of EORTC and DAPROCA studies in advanced prostatic cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
Zoladex and flutamide versus bilateral orchiectomy. A randomized phase III EORTC 30853 study. The EORTC GU Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Flutamide; Goserelin; Humans; Male; Middle Aged; Multicenter Studies as Topic; Orchiectomy; Prognosis; Prostatic Neoplasms; Radionuclide Imaging; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
Complete androgen blockade: data from an EORTC 30853 trial.
Topics: Aged; Anilides; Buserelin; Combined Modality Therapy; Europe; Flutamide; Goserelin; Humans; Male; Middle Aged; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
Topics: Aged; Androgen Antagonists; Anilides; Buserelin; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Random Allocation | 1990 |
Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
Topics: Buserelin; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Leuprolide; Middle Aged; Pilot Projects; Preoperative Care; Progestins; Time Factors; Uterine Neoplasms; Uterus | 1990 |
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
Topics: Adult; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Ovariectomy | 1990 |
The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
Topics: Adult; Buserelin; Danazol; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone | 1990 |
Secondary treatment of advanced cancer of the prostate with Zoladex.
Topics: Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Goserelin; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Remission Induction | 1990 |
New trends in the endocrine treatment of breast cancer.
Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis.
Topics: Adult; Androgens; Blood Glucose; Buserelin; C-Peptide; Danazol; Endometriosis; Female; Follicle Stimulating Hormone; Glucagon; Glucose Tolerance Test; Goserelin; Humans; Insulin; Luteinizing Hormone; Testosterone | 1990 |
Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy.
Topics: Buserelin; Diarrhea; Flutamide; Goserelin; Humans; Male; Prostatic Neoplasms; Radiotherapy | 1990 |
Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomata uteri.
Topics: Adult; Anemia, Hypochromic; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Leiomyoma; Menorrhagia; Middle Aged; Uterine Neoplasms | 1990 |
Orchidectomy versus Zoladex plus Eulexin in patients with metastatic prostate cancer (EORTC 30853).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Combinations; Drug Evaluation; Europe; Flutamide; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Risk Factors | 1990 |
Zoladex plus tamoxifen versus Zoladex alone in pre- and peri-menopausal metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cell Transformation, Neoplastic; Female; Freezing; Goserelin; Humans; Immunoenzyme Techniques; Middle Aged; Receptors, Estrogen; Remission Induction; Solubility; Tamoxifen | 1990 |
[Zoladex in prostatic carcinoma].
Topics: Aged; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; Male; Prostatic Neoplasms | 1990 |
[Goserelin depot: an analog of LHRH for the treatment of endometriosis].
Topics: Buserelin; Danazol; Delayed-Action Preparations; Endometriosis; Female; Goserelin; Humans | 1990 |
[How can a nursing team participate in a clinical trial? Zoladex, flutamide trial].
Topics: Buserelin; Clinical Trials as Topic; Flutamide; Goserelin; Humans; Job Description; Male; Nursing Staff, Hospital; Prostatic Neoplasms | 1990 |
A new longer-acting LHRH analog depot: preliminary results of a Dutch open phase II clinical study on a 10.8 mg Zoladex 3-monthly depot.
Topics: Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Drug Evaluation; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1990 |
Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Topics: Androgen Antagonists; Breast; Buserelin; Cardiovascular Diseases; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Goserelin; Humans; Male; Prospective Studies; Prostatic Neoplasms | 1990 |
A multicenter trial comparing the luteinizing hormone releasing hormone analog Zoladex, with Zoladex plus flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
Topics: Buserelin; Flutamide; Goserelin; Humans; Male; Prostatic Neoplasms | 1990 |
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU Group.
Topics: Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Carcinoma; Combined Modality Therapy; Flutamide; Follow-Up Studies; Goserelin; Humans; Liver Function Tests; Male; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Survival Rate | 1990 |
Zoladex plus flutamide vs. orchidectomy for advanced prostatic cancer. Danish Prostatic Cancer Group (DAPROCA).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Combined Modality Therapy; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Survival Rate | 1990 |
Total androgen blockade with Zoladex plus flutamide vs. Zoladex alone in advanced prostatic carcinoma: interim report of a multicenter, double-blind, placebo-controlled study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Double-Blind Method; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Survival Rate | 1990 |
Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Italian Prostatic Cancer Project (PONCAP).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Survival Rate | 1990 |
Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cyproterone; Cyproterone Acetate; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Prostatic Neoplasms; Testosterone | 1990 |
The role of prostate specific antigen in the baseline assessment of patients undergoing hormone therapy for advanced prostate cancer.
Topics: Acid Phosphatase; Alkaline Phosphatase; Antigens, Neoplasm; Biomarkers, Tumor; Bone Neoplasms; Buserelin; Diethylstilbestrol; Goserelin; Humans; Male; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Random Allocation | 1987 |
Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma.
Topics: Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms | 1989 |
Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma.
Topics: Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Random Allocation; United Kingdom | 1989 |
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Injections, Subcutaneous; Menopause; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Remission Induction | 1989 |
Zoladex and flutamide vs orchidectomy: a phase III EORTC 30853 trial. EORTC Urological Group.
Topics: Anilides; Buserelin; Clinical Trials as Topic; Europe; Flutamide; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prognosis; Prospective Studies; Prostatic Neoplasms; Random Allocation | 1989 |
'Zoladex' versus 'Zoladex' plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial. International Prostate Cancer Study Group.
Topics: Aged; Anilides; Buserelin; Clinical Trials as Topic; Drug Therapy, Combination; Flutamide; Goserelin; Humans; International Cooperation; Male; Multicenter Studies as Topic; Prognosis; Prostatic Neoplasms; Random Allocation | 1989 |
A comparison between surgical orchidectomy and the LHRH agonist 'Zoladex' (ICI 188630) in the treatment of metastatic cancer of the prostate.
Topics: Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Random Allocation; United Kingdom | 1989 |
A phase III open randomized study of Zoladex 3.6 mg depot vs. DES 3 mg per day in untreated advanced prostate cancer: a West Midlands Urological Research Group Study.
Topics: Aged; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Diethylstilbestrol; Goserelin; Humans; Male; Multicenter Studies as Topic; Prostatic Neoplasms; Random Allocation; United Kingdom | 1989 |
LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Buserelin; Carcinoma; Combined Modality Therapy; Delayed-Action Preparations; Goserelin; Humans; Male; Middle Aged; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms | 1989 |
Endocrine treatment of prostate cancer.
Topics: Androgen Antagonists; Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1989 |
Zoladex in the treatment of premenopausal metastatic breast cancer patients.
Topics: Abdominal Neoplasms; Bone Neoplasms; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Multicenter Studies as Topic | 1989 |
A multi-centre randomised study to compare the effects of ovarian ablation with Zoladex depot in pre- and perimenopausal patients with advanced breast cancer.
Topics: Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Multicenter Studies as Topic; Ovariectomy; Randomized Controlled Trials as Topic | 1989 |
Goserelin--the British multicentre trial.
Topics: Adult; Breast; Buserelin; Female; Goserelin; Humans; Middle Aged; Pain; Placebos; United Kingdom | 1989 |
Goserelin therapy before surgery for uterine fibroids.
Topics: Adult; Buserelin; Drug Evaluation; Female; Goserelin; Humans; Leiomyoma; Middle Aged; Pilot Projects; Premedication; Uterine Neoplasms | 1987 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
[Treatment of cancer of the prostate with Zoladex Depot].
Topics: Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Male; Prostatic Neoplasms | 1986 |
Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer.
Topics: Buserelin; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Prostatic Neoplasms; Radioimmunoassay; Testosterone; Time Factors | 1986 |
Zoladex (ICI 118,630): clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma.
Topics: Adenocarcinoma; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Prostatic Neoplasms; Random Allocation; Time Factors | 1987 |
[Treatment of prostatic carcinoma with daily subcutaneous injection of the LH-RH analogue, ICI 118630].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Drug Evaluation; Gonadotropins, Pituitary; Goserelin; Humans; Injections, Subcutaneous; Male; Middle Aged; Prostatic Neoplasms; Random Allocation | 1986 |
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Drug Evaluation; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Statistics as Topic; Testosterone | 1987 |
Treatment of patients with advanced cancer of the prostate: phase III trial, zoladex against castration; a study of the British Prostate Group.
Topics: Buserelin; Clinical Trials as Topic; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Random Allocation; Testosterone | 1987 |
Quality of life assessment in prostatic cancer.
Topics: Buserelin; Clinical Trials as Topic; Europe; Flutamide; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Quality of Life; Surveys and Questionnaires | 1988 |
LHRH-analogues therapy for metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Goserelin; Humans; Male; Middle Aged; Netherlands; Prostatic Neoplasms; Testosterone | 1988 |
A comparison between surgical orchidectomy and LH-RH analogue ('Zoladex', ICI 118,630) in the treatment of advanced prostatic carcinoma--a multi-centre clinical study.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Clinical Trials as Topic; Combined Modality Therapy; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Random Allocation | 1988 |
[Endocrine therapy of prostatic carcinoma with slow release (depot) formulation of the LH-RH analog ICI 118630 (Zoladex)].
Topics: Buserelin; Delayed-Action Preparations; Drug Evaluation; Goserelin; Humans; Male; Prostatic Neoplasms | 1988 |
Effects of long term GnRH analogue treatment on hormone levels and spermatogenesis in patients with carcinoma of the prostate.
Topics: Aged; Aged, 80 and over; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Hormones; Humans; Male; Middle Aged; Prostatic Neoplasms; Spermatogenesis; Time Factors | 1988 |
Selected advances in therapy of urologic cancer--luteinizing hormone releasing hormone (LHRH) and biologic response modifier (BUR).
Topics: Adenocarcinoma; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Interleukin-2; Male; Orchiectomy; Prostatic Neoplasms; Random Allocation; Recombinant Proteins | 1988 |
Evaluation of total versus partial androgen blockade in the treatment of advanced prostatic cancer.
Topics: Androgen Antagonists; Androgens; Buserelin; Flutamide; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Random Allocation | 1988 |
Total androgen blockade in advanced prostatic cancer. Critical review and personal experience.
Topics: Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Time Factors | 1988 |
[Clinical efficacy of long-term treatment with LH-RH analogue, ICI 118630 (Zoladex), in prostatic cancer patients. The Zoladex Multicenter Study Group].
Topics: Buserelin; Drug Evaluation; Goserelin; Humans; Male; Multicenter Studies as Topic; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
LH-RH agonist, Zoladex (Goserelin), depot formulation in the treatment of prostatic cancer. Randomized dose-finding trial in Japan.
Topics: Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Japan; Luteinizing Hormone; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Random Allocation; Remission Induction; Testosterone | 1988 |
Zoladex as primary therapy in advanced prostatic cancer. A French cooperative trial.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Follicle Stimulating Hormone; France; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prospective Studies; Prostate; Prostatic Neoplasms | 1988 |
U.K. trials of treatment for M1 prostatic cancer. The LH-RH analogue Zoladex vs. orchidectomy.
Topics: Aged; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Remission Induction; Testosterone; United Kingdom | 1988 |
Interim report of a randomized trial comparing Zoladex 3.6 mg depot with diethylstilbestrol 3 mg/day in advanced prostate cancer. The West Midlands Urology Research Group.
Topics: Buserelin; Delayed-Action Preparations; Diethylstilbestrol; England; Follow-Up Studies; Goserelin; Humans; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Random Allocation; Remission Induction; Testosterone | 1988 |
[Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].
Topics: Aged; Buserelin; Castration; Clinical Trials as Topic; Estrogens; Goserelin; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prostatic Neoplasms | 1988 |
An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
Topics: Buserelin; Carcinoma; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone; Time Factors | 1985 |
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex).
Topics: Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Luteinizing Hormone; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Testosterone | 1984 |
Pituitary down-regulation prior to in-vitro fertilization and embryo transfer: a comparison between a single dose of Zoladex depot and multiple daily doses of Suprefact.
Topics: Adult; Buserelin; Down-Regulation; Drug Administration Schedule; Embryo Transfer; Female; Fertilization in Vitro; Goserelin; Humans; Pituitary Gland; Pregnancy; Reproductive Techniques | 1995 |
Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study.
Topics: Administration, Intranasal; Adult; Buserelin; Down-Regulation; Female; Fertilization in Vitro; Goserelin; Humans; Injections, Subcutaneous; Pituitary Gland | 1993 |
Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up.
Topics: Adolescent; Adult; Buserelin; Endometriosis; Female; Follow-Up Studies; Goserelin; Humans; Middle Aged; Nafarelin; Prospective Studies; Recurrence | 1993 |
The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials. European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Tract Cancer Cooperative Group.
Topics: Aged; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone Acetate; Disease-Free Survival; Flutamide; Goserelin; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Survival Rate | 1998 |
231 other study(ies) available for buserelin and goserelin
| Article | Year |
|---|---|
[Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].
Topics: Adult; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Receptors, LHRH; Uterine Neoplasms | 1992 |
Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy.
Topics: Adult; Buserelin; Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Medroxyprogesterone; Pelvic Neoplasms | 1992 |
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP.
Topics: Antineoplastic Agents; Binding Sites; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Methionine; Prostatic Neoplasms; Receptors, LHRH; Thymidine; Tumor Cells, Cultured | 1992 |
Catamenial epilepsy and goserelin.
Topics: Buserelin; Combined Modality Therapy; Epilepsy; Estrogen Replacement Therapy; Female; Goserelin; Humans; Menstruation | 1992 |
Differential effects of LHRH and somatostatin analogs on human breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Carcinoma; Cell Division; Estrogens; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; In Vitro Techniques; Somatostatin; Triptorelin Pamoate; Tumor Cells, Cultured | 1992 |
Novel antitumor peptide hormones and their effect on signal transduction.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Molecular Sequence Data; Peptides; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Signal Transduction; Somatostatin; Tumor Cells, Cultured | 1992 |
Value of biochemical markers in the management of disseminated prostatic cancer.
Topics: Acid Phosphatase; Alkaline Phosphatase; Antigens, Neoplasm; Biomarkers, Tumor; Buserelin; Follow-Up Studies; Goserelin; Humans; Male; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors | 1992 |
Response to second-line hormonal manipulation monitored by serum PSA in stage D2 prostate carcinoma.
Topics: Androgen Antagonists; Anilides; Antigens, Neoplasm; Biomarkers, Tumor; Buserelin; Goserelin; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 1992 |
Quantitative estimation of tissue prostate specific antigen, deoxyribonucleic acid ploidy and cytological grade in fine needle aspiration biopsies for prognosis of hormonally treated prostatic carcinoma.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Biopsy, Needle; Buserelin; DNA, Neoplasm; Estrogens; Follow-Up Studies; Goserelin; Humans; Male; Multivariate Analysis; Orchiectomy; Ploidies; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms | 1992 |
Effects of the gonadotrophin-releasing hormone agonist 'Zoladex' upon pituitary and gonadal function in hypogonadal (hpg) male mice: a comparison with normal male and testicular feminized (tfm) mice.
Topics: Androgens; Animals; Buserelin; Feminization; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Goserelin; Hypogonadism; Luteinizing Hormone; Male; Mice; Orchiectomy; Organ Size; Pituitary Gland; Reference Values; Testis | 1992 |
The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month.
Topics: Buserelin; Estradiol; Female; Goserelin; Humans; Leiomyoma; Remission Induction; Retrospective Studies; Time Factors; Uterine Neoplasms | 1992 |
Laparoscopic aspiration of ovarian endometriomas. Effect with postoperative gonadotropin releasing hormone agonist treatment.
Topics: Adult; Analysis of Variance; Biopsy, Needle; Buserelin; Endometriosis; Female; Goserelin; Humans; Laparoscopy; Ovarian Neoplasms; Prospective Studies; Suction; Ultrasonography | 1992 |
Effects of chronic gonadotropin-releasing hormone agonist treatment on serum luteinizing hormone and testosterone concentrations in boars.
Topics: Animals; Buserelin; Drug Implants; Goserelin; Luteinizing Hormone; Male; Random Allocation; Swine; Testosterone | 1992 |
Treatment of peri-menopausal women: potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy.
Topics: Adult; Bone Density; Buserelin; Climacteric; Delayed-Action Preparations; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Follow-Up Studies; Goserelin; Humans; Leiomyoma; Middle Aged; Uterine Neoplasms | 1992 |
The place of GnRH agonists in the treatment of endometriosis and fibroids by advanced endoscopic techniques.
Topics: Adult; Buserelin; Combined Modality Therapy; Endometriosis; Female; Goserelin; Humans; Hysteroscopy; Leiomyoma; Myometrium; Ovarian Neoplasms; Prospective Studies; Uterine Neoplasms | 1992 |
Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients.
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cortisone; Female; Goserelin; Humans; Insulin-Like Growth Factor I; Menopause; Middle Aged; Tamoxifen | 1992 |
Re: Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma. A. V. Kaisary et al. Br. J. Urol., 67, 502-508, 1991.
Topics: Antineoplastic Agents; Buserelin; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms | 1992 |
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen | 1992 |
Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Mammary Neoplasms, Experimental; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Time Factors; Uterus | 1992 |
Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group.
Topics: Adult; Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadal Steroid Hormones; Goserelin; Humans; Pregnancy; Uterine Hemorrhage | 1992 |
[A 79-year-old man with metastatic prostate cancer, treated with Zoladex, flutamide, calcitonin and Ostac, suffers from frequent troublesome sweating with palpitation and angina pectoris, especially at night. Is there a therapy?].
Topics: Aged; Androgen Antagonists; Angina Pectoris; Buserelin; Calcitonin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Hyperhidrosis; Male; Prostatic Neoplasms | 1992 |
Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery.
Topics: Adult; Buserelin; Contraindications; Female; Goserelin; Humans; Hysterectomy; Menorrhagia; Middle Aged | 1992 |
Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
Topics: Adult; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Leiomyoma; Middle Aged; Preoperative Care; Uterine Neoplasms | 1992 |
Treatment of pre-menopausal advanced breast cancer with goserelin--a long-acting luteinizing hormone releasing hormone agonist.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Middle Aged; Progesterone | 1992 |
Hormonal cytoreduction and radiotherapy for carcinoma of the prostate.
Topics: Buserelin; Combined Modality Therapy; Goserelin; Humans; Male; Prostatic Neoplasms | 1992 |
Pituitary hyperplasia after goserelin (LHRH-analogue) therapy.
Topics: Adrenocorticotropic Hormone; Aged; Buserelin; Goserelin; Growth Hormone; Humans; Hyperplasia; Immunohistochemistry; Male; Neoplasm Metastasis; Orchiectomy; Pituitary Gland, Anterior; Prostatic Neoplasms | 1991 |
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
Topics: Adult; Antineoplastic Agents; Bone Density; Buserelin; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Pilot Projects; Triglycerides; Uterine Neoplasms | 1991 |
Catamenial epilepsy and goserelin.
Topics: Adult; Buserelin; Female; Goserelin; Humans; Male; Menstruation; Status Epilepticus | 1991 |
Prostate-specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Brachytherapy; Buserelin; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms | 1990 |
Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancer.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Buserelin; Flutamide; Goserelin; Humans; Male; Orchiectomy; Predictive Value of Tests; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Survival Rate | 1990 |
Goserelin--another LH-RH analog for prostate cancer.
Topics: Buserelin; Drug Implants; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Palliative Care; Prostatic Neoplasms | 1990 |
Response to orchiectomy following Zoladex therapy for metastatic prostate carcinoma.
Topics: Aged; Antigens, Neoplasm; Buserelin; Combined Modality Therapy; Goserelin; Humans; Male; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1991 |
Effect of LH-RH analogue in patients with benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Buserelin; Goserelin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Ultrasonography; Urinary Retention | 1991 |
[Gn-RH analogs and benign prostatic hypertrophy].
Topics: Antineoplastic Agents; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Prostatic Hyperplasia | 1990 |
Medical treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Androstenes; Azasteroids; Buserelin; Finasteride; Goserelin; Humans; Leuprolide; Male; Prostatic Hyperplasia | 1991 |
Prolactin and pituitary gonadotropin values and responses to acute luteinizing hormone-releasing hormone (LHRH) challenge in patients having long-term treatment with a depot LHRH analogue.
Topics: Aged; Buserelin; Follicle Stimulating Hormone; Gonadotropins; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prolactin; Prostatic Neoplasms; Testosterone | 1991 |
Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.
Topics: Adult; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Lung; Lung Neoplasms; Lymphangiomyoma; Progesterone; Radiography; Testosterone | 1991 |
Bone mass in endometriosis patients treated with GnRH agonist implant or danazol.
Topics: Adult; Alkaline Phosphatase; Bone Density; Buserelin; Danazol; Drug Implants; Endometriosis; Estradiol; Female; Femur Neck; Follow-Up Studies; Genital Neoplasms, Female; Goserelin; Humans; Random Allocation; Spine | 1991 |
Cryopreservation of human embryos at the pronucleate, early cleavage, or expanded blastocyst stages.
Topics: Blastocyst; Buserelin; Cleavage Stage, Ovum; Clomiphene; Cryopreservation; Cryoprotective Agents; Embryo Transfer; Evaluation Studies as Topic; Female; Fertilization in Vitro; Gamete Intrafallopian Transfer; Goserelin; Humans; Menotropins; Ovary; Pregnancy; Propylene Glycol; Propylene Glycols | 1991 |
Lymphangitic carcinomas of the lung as presentation of prostatic cancer. A case report.
Topics: Buserelin; Carcinoma; Flutamide; Goserelin; Humans; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Prostatic Neoplasms | 1991 |
Medical or surgical orchidectomy: the patients' choice.
Topics: Aged; Buserelin; Choice Behavior; Consumer Behavior; Goserelin; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms | 1991 |
Preferential preservation of bone mineralisation by LHRH agonists in the treatment of metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Density; Buserelin; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms | 1991 |
Correlations between follicular fluid steroid analysis and maturity and cytogenetic analysis of human oocytes that remained unfertilized after in vitro fertilization.
Topics: 17-alpha-Hydroxyprogesterone; 20-alpha-Dihydroprogesterone; Androstenedione; Buserelin; Chromosomes; Clomiphene; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Goserelin; Humans; Hydroxyprogesterones; Karyotyping; Male; Menotropins; Oocytes; Ploidies; Progesterone; Progestins; Steroids | 1991 |
Effects of the duration of therapy with the LHRH agonist D-ser (BUT)6 Azgly10-LHRH (ICI 118-630) on the steroid hormone content and the morphology of human testicular tissue in the treatment of patients with advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Androgens; Antineoplastic Agents; Buserelin; Goserelin; Humans; Male; Prostatic Neoplasms; Testis; Time Factors | 1991 |
Medical castration with zoladex: a conservative approach to premenopausal breast cancer.
Topics: Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Ovariectomy; Receptors, Estrogen | 1991 |
Pretreatment with Zoladex improves surgery for uterine fibroids.
Topics: Buserelin; Female; Goserelin; Humans; Hysterectomy; Leiomyoma; Premedication; Uterine Neoplasms | 1991 |
[Report of the International Symposium on "Zoladex--the new therapy concept in breast cancer" Cambridge, 9-11 September 1990].
Topics: Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent | 1991 |
Combined goserelin and tamoxifen in premenopausal advanced breast cancer: duration of response and survival.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Middle Aged; Tamoxifen | 1991 |
Treatment with different GnRH analogues in women: preliminary evidence for disparant effects on serum androgen concentrations.
Topics: Adult; Androgens; Buserelin; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Triptorelin Pamoate | 1991 |
Recurring catamenial pneumothorax treated with a Gn-RH analogue.
Topics: Adult; Buserelin; Endometriosis; Female; Goserelin; Humans; Menstruation; Pleural Neoplasms; Pneumothorax; Recurrence | 1991 |
Effects of castration, alone and in combination with aminoglutethimide, on growth of (pre)neoplastic lesions in exocrine pancreas of rats and hamsters.
Topics: Aminoglutethimide; Animals; Azaserine; Body Weight; Buserelin; Carcinogens; Cricetinae; Epidermal Growth Factor; Gastrins; Goserelin; Male; Mesocricetus; Nitrosamines; Orchiectomy; Organ Size; Pancreatic Neoplasms; Precancerous Conditions; Rats; Rats, Inbred Strains; Somatomedins; Testosterone | 1991 |
Goserelin versus danazol in the treatment of endometriosis.
Topics: Bone Density; Buserelin; Danazol; Endometriosis; Female; Goserelin; Humans; Pelvic Neoplasms | 1991 |
The management of leiomyoma uteri by GnRH analogues.
Topics: Adult; Buserelin; Delayed-Action Preparations; Female; Goserelin; Hemoglobins; Humans; Leiomyoma; Middle Aged; Pregnancy; Remission Induction; Ultrasonography; Uterine Neoplasms | 1991 |
An unusual complication of gamete intra-fallopian transfer (GIFT).
Topics: Abscess; Adult; Bacteroides Infections; Buserelin; Female; Gamete Intrafallopian Transfer; Goserelin; Humans; Menotropins; Ovarian Diseases; Ovulation Induction | 1991 |
Treatment of a patient with severe menstrual migraine using the depot LHRH analogue Zoladex.
Topics: Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Menstruation; Migraine Disorders | 1991 |
Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Buserelin; Cell Division; Female; Goserelin; Humans; Immunohistochemistry; Menopause; Predictive Value of Tests; Receptors, Estrogen; Tamoxifen | 1991 |
Management of the painful and nodular breast.
Topics: Adult; Age Factors; Breast Diseases; Bromocriptine; Buserelin; Danazol; Estrogen Replacement Therapy; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Goserelin; Humans; Hypolipidemic Agents; Linoleic Acids; Oenothera biennis; Pain; Plant Oils; Tamoxifen | 1991 |
Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosis.
Topics: Adult; Buserelin; Delayed-Action Preparations; Endometriosis; Estradiol; Female; Goserelin; Humans; Luteinizing Hormone; Pregnancy; Pregnancy Outcome; Progesterone; Prolactin; Testosterone | 1991 |
The influence of reproductive status on vasopressin release in the rat.
Topics: Animals; Buserelin; Estrus; Female; Goserelin; Osmolar Concentration; Ovariectomy; Ovary; Pituitary Gland; Rats; Rats, Inbred Strains; Tamoxifen; Vasopressins; Water-Electrolyte Balance | 1991 |
Orchidectomy or LHRH-analogue? Which do the patients prefer and what treatment would Norwegian urologists prefer if they had advanced cancer of the prostate?
Topics: Adult; Aged; Aged, 80 and over; Attitude of Health Personnel; Buserelin; Goserelin; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms | 1991 |
Immunohistochemical localization of epidermal growth factor receptor in leiomyomas from women treated with goserelin depot.
Topics: Adult; Buserelin; Delayed-Action Preparations; ErbB Receptors; Female; Goserelin; Humans; Immunohistochemistry; Leiomyoma; Middle Aged; Myometrium; Ultrasonography; Uterine Neoplasms | 1991 |
Bone marrow regeneration after hormonal therapy in patients with bone metastases from prostate carcinoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Bone Marrow; Bone Neoplasms; Buserelin; Flutamide; Goserelin; Humans; Male; Middle Aged; Organotechnetium Compounds; Prostatic Neoplasms; Radionuclide Imaging; Regeneration | 1991 |
The combination of a depot gonadotrophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding.
Topics: Adult; Buserelin; Drug Therapy, Combination; Estradiol; Female; Goserelin; Humans; Injections, Subcutaneous; Menorrhagia; Middle Aged; Prospective Studies; Treatment Outcome | 1991 |
Maximal androgen blockade in prostatic cancer.
Topics: Androgen Antagonists; Buserelin; Flutamide; Goserelin; Humans; Imidazoles; Imidazolidines; Leuprolide; Male; Orchiectomy; Prostatic Neoplasms | 1991 |
[Differential effects of GnRH analogs on androgen concentrations in females].
Topics: Adult; Androgens; Antineoplastic Agents; Buserelin; Drug Implants; Endometriosis; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Injections, Intramuscular; Leiomyoma; Luteinizing Hormone; Triptorelin Pamoate; Uterine Neoplasms | 1991 |
The effect of various gonadotrophin-releasing hormone regimens on gonadotrophins, follicular growth and ovulation in deeply anoestrous mares.
Topics: Anestrus; Animals; Buserelin; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Equine; Goserelin; Horses; Luteinizing Hormone; Ovarian Follicle; Ovulation | 1991 |
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen | 1990 |
Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
Topics: Animals; Buserelin; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Goserelin; Male; Organ Size; Procarbazine; Rats; Rats, Inbred Strains; Receptors, LH; Seminiferous Tubules; Sperm Count; Spermatogenesis; Spermatogonia; Testis | 1990 |
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen | 1990 |
[Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
Topics: Adult; Buserelin; Combined Modality Therapy; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Leiomyoma; Luteinizing Hormone; Progesterone; Ultrasonography; Uterine Neoplasms; Uterus | 1990 |
Predictive initial parameters for response of stage D prostate cancer to treatment with the luteinizing hormone-releasing hormone agonist goserelin.
Topics: Age Factors; Aged; Alkaline Phosphatase; Analysis of Variance; Antineoplastic Agents; Buserelin; Goserelin; Health Status; Humans; Male; Multivariate Analysis; Neoplasm Staging; Pain; Predictive Value of Tests; Proportional Hazards Models; Prostatic Neoplasms; Remission Induction; Testosterone | 1990 |
Testicular histology after treatment with LH-RH analogue for carcinoma of the prostate.
Topics: Aged; Buserelin; Goserelin; Humans; Leydig Cells; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Spermatogenesis; Testis; Testosterone; Time Factors | 1990 |
[Goserelin].
Topics: Buserelin; Goserelin; Humans | 1990 |
Suppression of plasma androgens by the antiandrogen flutamide in prostatic cancer patients treated with Zoladex, a GnRH analogue.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androgens; Androstenedione; Anilides; Antineoplastic Agents; Buserelin; Dehydroepiandrosterone; Depression, Chemical; Flutamide; Goserelin; Humans; Hydroxyprogesterones; Male; Orchiectomy; Prostatic Neoplasms; Testosterone | 1990 |
The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
Topics: Adult; Aged; Biological Assay; Buserelin; Endometriosis; Female; Fluorescent Antibody Technique; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Menopause; Middle Aged; Nafarelin; Orchiectomy; Ovarian Neoplasms; Ovariectomy; Prostatic Neoplasms; Radioimmunoassay; Uterine Neoplasms | 1990 |
Regulation of the pituitary 5 alpha-reductase activity by gonadotropin releasing hormone and testosterone in the adult male rat.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Hypothalamus; Male; Orchiectomy; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Propionates; Rats; Rats, Inbred Strains; Testosterone | 1990 |
Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspects.
Topics: Breast Neoplasms; Buserelin; Estradiol; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Menopause; Polyunsaturated Alkamides; Tamoxifen | 1990 |
LHRH analogue for treatment of recurrent and refractory mastalgia.
Topics: Adult; Breast; Buserelin; Climacteric; Delayed-Action Preparations; Female; Goserelin; Humans; Middle Aged; Pain | 1990 |
Zoladex said to be "as effective as surgery" for prostate cancer.
Topics: Buserelin; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms | 1990 |
EORTC protocol 30853: orchidectomy versus zoladex plus flutamide in the management of metastatic carcinoma of the prostate. Interim statistical analysis of the side effects of treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Goserelin; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms | 1990 |
Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Luteinizing Hormone; Male; Premedication; Prostatic Neoplasms; Testosterone; Time Factors | 1990 |
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen | 1990 |
Treatment with an LHRH analogue in patients with advanced pancreatic cancer. A preliminary report.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Buserelin; Drug Implants; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies | 1990 |
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
Topics: Adult; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Receptors, Estrogen; Survival Rate; Time Factors | 1990 |
Reversal of ageing changes in the thymus of rats by chemical or surgical castration.
Topics: Aging; Animals; Body Weight; Buserelin; Goserelin; Immunohistochemistry; Male; Orchiectomy; Organ Size; Rats; Rats, Inbred Strains; Thymus Gland | 1990 |
Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.
Topics: Adult; Buserelin; Delayed-Action Preparations; Endocrine Glands; Endometriosis; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Goserelin; Humans; Menstrual Cycle; Prolactin | 1990 |
Serum growth factor following primary tumor removal and the inhibition of its production by preoperative therapy.
Topics: Animals; Buserelin; Combined Modality Therapy; Culture Media; Cyclophosphamide; Female; Goserelin; Growth Substances; In Vitro Techniques; Mice; Neoplasms, Experimental; Preoperative Care; Tamoxifen; Tritium | 1990 |
[Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Animals; Buserelin; Carcinoma; Drug Implants; Goserelin; Humans; Male; Middle Aged; Organ Size; Prospective Studies; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testis; Testosterone | 1990 |
A new extra long acting depot preparation of the LHRH analogue Zoladex. First endocrinological and pharmacokinetic data in patients with advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Buserelin; Drug Tolerance; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Gland; Prostatic Neoplasms; Testosterone | 1990 |
[Goserelin--a new form of hormone therapy in ovarian cancer].
Topics: Adult; Aged; Buserelin; Combined Modality Therapy; Delayed-Action Preparations; Female; Follow-Up Studies; Goserelin; Humans; Injections, Subcutaneous; Middle Aged; Ovarian Neoplasms | 1990 |
Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex).
Topics: Acid Phosphatase; Aged; Aged, 80 and over; alpha-2-HS-Glycoprotein; Antigens; Blood Proteins; Buserelin; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Orosomucoid; Prolactin; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Testosterone | 1986 |
[Hormone therapy of male genital cancer (prostatic cancer)].
Topics: Buserelin; Chlormadinone Acetate; Estramustine; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Nitrogen Mustard Compounds; Prostatic Neoplasms | 1987 |
Epidermal growth factor receptors in human hyperplastic prostate tissue and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
Topics: Aged; Binding Sites; Buserelin; Dihydrotestosterone; Epidermal Growth Factor; ErbB Receptors; Goserelin; Humans; Male; Middle Aged; Models, Biological; Prostatic Hyperplasia; Testosterone | 1989 |
Suppression of gonadotrophin secretion does not reverse premature ovarian failure.
Topics: Adult; Amenorrhea; Buserelin; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Menotropins; Ovarian Diseases; Ovary | 1989 |
Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice.
Topics: Animals; Buserelin; Combined Modality Therapy; Cyclophosphamide; DNA; Female; Goserelin; Growth Substances; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Tamoxifen | 1989 |
[New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex].
Topics: Adult; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Injections, Subcutaneous; Leiomyoma; Neoplasms, Hormone-Dependent; Ultrasonography; Uterine Neoplasms; Uterus | 1989 |
Patients' choice of treatment in stage D prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Attitude to Health; Buserelin; Consumer Behavior; Decision Making; Follow-Up Studies; Goserelin; Humans; Informed Consent; Male; Middle Aged; Orchiectomy; Patient Participation; Prostatic Neoplasms; Surveys and Questionnaires | 1989 |
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Progesterone; Tamoxifen | 1989 |
Effects of gonadotropin-releasing hormone and its agonists on prolactin secretion from normal and tumorous pituitary cells.
Topics: Animals; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; In Vitro Techniques; Luteinizing Hormone; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Reference Values | 1989 |
[Treatment of cancer of the prostate. Role of gonadorelin analogs].
Topics: Buserelin; Castration; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Prostatic Neoplasms | 1989 |
Gonadotropin-releasing hormone agonist inhibits physiologic ovarian follicular loss in rats.
Topics: Animals; Buserelin; Cell Count; Cell Division; Female; Goserelin; Oocytes; Organ Size; Ovarian Follicle; Ovary; Rats; Rats, Inbred Strains | 1989 |
Cornual fibroids: a conservative approach to restoring tubal patency using a gonadotropin-releasing hormone agonist (goserelin) with successful pregnancy.
Topics: Adult; Buserelin; Fallopian Tube Patency Tests; Fallopian Tubes; Female; Fibroma; Goserelin; Humans; Pregnancy; Uterine Neoplasms | 1989 |
The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).
Topics: Buserelin; Estradiol; Female; Goserelin; Humans; Leiomyoma; Menstrual Cycle; Myometrium; Progesterone; Receptors, Estradiol; Receptors, Progesterone; Uterine Neoplasms; Uterus | 1989 |
Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; Humans; Menopause; Middle Aged; Tamoxifen | 1989 |
Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cytosol; Drug Implants; Estrenes; Female; Follicle Stimulating Hormone; Goserelin; Injections, Subcutaneous; Luteinizing Hormone; Mammary Neoplasms, Experimental; Mifepristone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen | 1989 |
[Clinical and endocrinological studies of the luteinizing hormone-releasing hormone analogue therapy in prostatic cancer patients].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgens; Antineoplastic Agents; Buserelin; Dihydrotestosterone; Drug Evaluation; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Remission Induction; Testosterone | 1989 |
[Zoladex as a depot GnRH agonist in premenopausal metastatic breast cancer].
Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Middle Aged | 1989 |
Effect of treatment with gonadotropin-releasing hormone analogues on pregnancy outcome in the baboon.
Topics: Animals; Buserelin; Chorionic Gonadotropin; Female; Gonadotropin-Releasing Hormone; Goserelin; Pituitary Hormone-Releasing Hormones; Pregnancy; Pregnancy Outcome; Pregnancy, Animal; Progesterone | 1989 |
Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids.
Topics: Amenorrhea; Buserelin; Creatinine; Drug Therapy, Combination; Estradiol; Estrogens; Female; Fibrosis; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Progesterone; Tamoxifen; Uterine Diseases | 1989 |
Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy.
Topics: Bone Neoplasms; Buserelin; Female; Goserelin; Granulosa Cell Tumor; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Pituitary Hormone-Releasing Hormones | 1989 |
Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Nolvadex) therapy in premenopausal women with breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Middle Aged; Tamoxifen | 1989 |
Effect of GnRH agonists on the thymus in female rats.
Topics: Animals; Bone Marrow; Buserelin; Female; Gonadotropin-Releasing Hormone; Goserelin; Leuprolide; Organ Size; Rats; Rats, Inbred Strains; Spleen; Thymus Gland | 1989 |
Androgens do not regulate the growth hormone response to GHRH in elderly men.
Topics: Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Goserelin; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1989 |
Rationale in use of LHRH analogues in endometriosis.
Topics: Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Nafarelin | 1989 |
The short-term use of luteinising hormone-releasing hormone analogues in uterine fibroids.
Topics: Buserelin; Female; Goserelin; Humans; Leiomyoma; Uterine Neoplasms | 1989 |
Mechanism of LHRH analogue action in uterine fibroids.
Topics: Buserelin; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Nafarelin; Uterine Neoplasms | 1989 |
Effect of treatment with LHRH analogue Zoladex on binding of oestradiol, progesterone and epidermal growth factor to uterine fibromyomata.
Topics: Buserelin; ErbB Receptors; Female; Goserelin; Humans; Leiomyoma; Receptors, Estradiol; Receptors, Progesterone; Uterine Neoplasms | 1989 |
Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
Topics: Buserelin; Cholesterol; Danazol; Endometriosis; Female; Goserelin; Humans; Lipoproteins; Pelvic Neoplasms; Pregnadienes; Risk Factors; Triglycerides | 1989 |
A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
Topics: Adult; Bone Density; Buserelin; Danazol; Endometriosis; Female; Goserelin; Humans; Osteoporosis; Pregnadienes | 1989 |
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancer.
Topics: Adult; Androstenedione; Breast Neoplasms; Buserelin; Estrone; Female; Goserelin; Humans; Middle Aged; Testosterone | 1989 |
Zoladex in advanced breast cancer.
Topics: Breast Neoplasms; Buserelin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Goserelin; Humans; Ovary; Tamoxifen | 1989 |
Endocrinology of Zoladex in postmenopausal women.
Topics: Androgens; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estrogens; Female; Gonadotropins, Pituitary; Goserelin; Humans; Menopause | 1989 |
Zoladex: therapeutic effects in postmenopausal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; Humans; Menopause; Middle Aged | 1989 |
Therapy in premenopausal women with advanced, oestrogen positive or/and progesterone positive breast cancer: surgical oophorectomy versus the LHRH analogue, Zoladex.
Topics: Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Ovariectomy; Receptors, Estrogen; Receptors, Progesterone | 1989 |
LHRH analogues in early breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Female; Fluorouracil; Goserelin; Humans; Methotrexate; Middle Aged | 1989 |
Luteinising hormone-releasing hormone analogues alone in the treatment of advanced disease.
Topics: Buserelin; Goserelin; Humans; Male; Prostatic Neoplasms | 1989 |
LHRH analogues in combination with an anti-androgen in the treatment of advanced disease.
Topics: Androgen Antagonists; Buserelin; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Male; Prostatic Neoplasms | 1989 |
Pharmacology of the luteinising hormone-releasing hormone (LHRH) analogue, Zoladex.
Topics: Animals; Buserelin; Female; Goserelin; Male; Mammary Neoplasms, Experimental; Prostatic Neoplasms; Rats | 1989 |
Clinical appreciation of LHRH analogue formulations.
Topics: Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Nafarelin; Triptorelin Pamoate | 1989 |
Clinical trials referral resource. Adjuvant therapy of breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Goserelin; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Menopause; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen | 1989 |
Testicular GnRH-receptors and direct effects of a GnRH-agonist on human testicular steroidogenesis.
Topics: Aged; Binding Sites; Buserelin; Goserelin; Humans; Male; Pregnenolone; Progesterone; Receptors, LHRH; Testis; Tritium | 1989 |
A response in advanced post-menopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist--Zoladex.
Topics: Aged; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Female; Goserelin; Humans; Menopause | 1989 |
A new treatment for endometriosis.
Topics: Administration, Cutaneous; Buserelin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Goserelin; Humans | 1989 |
Catecholamines relax portal and mesenteric veins from normal and portal hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Buserelin; Epinephrine; Goserelin; Hypertension, Portal; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Mesenteric Veins; Muscle, Smooth, Vascular; Norepinephrine; Portal Vein; Potassium Chloride; Rats; Rats, Inbred Strains; Reference Values; Vasodilation | 1989 |
Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Topics: Adrenocorticotropic Hormone; Animals; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Goserelin; Imidazoles; Imidazolidines; Ketoconazole; Luteinizing Hormone; Male; Orchiectomy; Organ Size; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains | 1988 |
Voluntary chemical castration of a mental patient.
Topics: Adolescent; Adult; Behavior Control; Buserelin; Goserelin; Humans; Informed Consent; Jurisprudence; Male; Mentally Ill Persons; Paraphilic Disorders; Patient Participation; Pedophilia; Research Subjects; Risk Assessment; Therapeutic Human Experimentation | 1988 |
Active immunization of gilts against gonadotropin-releasing hormone: effects on secretion of gonadotropins, reproductive function, and responses to agonists of gonadotropin-releasing hormone.
Topics: Animals; Autoantibodies; Buserelin; Estrus; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Immunity, Active; Immunization, Secondary; Luteinizing Hormone; Ovariectomy; Pituitary Hormone-Releasing Hormones; Prolactin; Swine | 1985 |
Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer.
Topics: Adult; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Pituitary Gland; Progesterone; Receptors, Estrogen; Time Factors | 1985 |
Antithrombin III concentration, thrombosis, and treatment with luteinising hormone releasing hormone agonist in prostatic carcinoma.
Topics: Aged; Antithrombin III; Buserelin; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms | 1986 |
Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate.
Topics: Buserelin; Cyproterone; Cyproterone Acetate; Goserelin; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Prostatic Neoplasms; Urologic Diseases | 1986 |
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Middle Aged; Progesterone; Receptors, Estrogen | 1986 |
[Phase I study with LH-RH agonist, ICI 118630].
Topics: Buserelin; Drug Evaluation; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Testosterone | 1986 |
Comparison of mammalian luteinizing hormone releasing hormone (LH-RH), and of an analog (ICI 118630), on luteinizing hormone and ovarian steroid (progesterone, oestradiol) secretions in laying hens. (Gallus domesticus).
Topics: Animals; Buserelin; Chickens; Dose-Response Relationship, Drug; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Luteinizing Hormone; Male; Ovary; Oviposition; Progesterone | 1986 |
[Treatment of advanced cancer of the prostate using LHRH analogs. How can a possible initial flare-up be prevented?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Diethylstilbestrol; Goserelin; Humans; Male; Prostatic Neoplasms | 1986 |
A new hormonal therapy for prostatic cancer: long-term clinical and hormonal response.
Topics: Aged; Aged, 80 and over; Buserelin; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone; Time Factors | 1986 |
Testosterone and gonadotrophin profiles in patients on daily or monthly LHRH analogue ICI 118630 (Zoladex) compared with orchiectomy.
Topics: Aged; Aged, 80 and over; Buserelin; Drug Administration Schedule; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer.
Topics: Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Hormones; Humans; Luteinizing Hormone; Menopause; Middle Aged; Progesterone | 1986 |
Treatment of advanced carcinoma of the prostate with a depot luteinizing hormone-releasing hormone analogue (ICI-118630).
Topics: Aged; Buserelin; Carcinoma; Delayed-Action Preparations; Diethylstilbestrol; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1987 |
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Goserelin; Humans; Lung Neoplasms; Luteinizing Hormone; Menopause; Middle Aged; Remission Induction | 1986 |
Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.
Topics: Adult; Buserelin; Delayed-Action Preparations; Depression, Chemical; Estradiol; Female; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Progesterone; Saliva | 1986 |
Effects of a single injection of a new depot formulation of an LH-releasing hormone agonist on spermatogenesis in adult rats.
Topics: Animals; Buserelin; Cell Division; Delayed-Action Preparations; Follicle Stimulating Hormone; Goserelin; Luteinizing Hormone; Male; Organ Size; Rats; Spermatogenesis; Testis; Testosterone | 1986 |
Regeneration of the thymus in old male rats treated with a stable analogue of LHRH.
Topics: Animals; Buserelin; Goserelin; Male; Orchiectomy; Organ Size; Prostate; Rats; Rats, Inbred Strains; Regeneration; Seminal Vesicles; Testis; Testosterone; Thymus Gland | 1987 |
[Treatment of carcinoma of the prostate with analogs of LHRH].
Topics: Androgen Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate | 1986 |
Stimulation of fetal growth associated with decreased maternal plasma oestrogen levels.
Topics: Animals; Buserelin; Embryonic and Fetal Development; Estradiol; Female; Fetal Blood; Gestational Age; Goserelin; Organ Size; Placenta; Pregnancy; Rats | 1987 |
[Clinical effect of slow release (depot) formulation of the LH-RH analogue ICI 118630 (Zoladex) in patients with prostatic carcinoma].
Topics: Aged; Buserelin; Delayed-Action Preparations; Drug Administration Schedule; Drug Evaluation; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1987 |
Response in post-menopausal patients on ICI 118630.
Topics: Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Lung Neoplasms; Middle Aged | 1987 |
The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI 118630.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Bone Neoplasms; Buserelin; Delayed-Action Preparations; Goserelin; Humans; Luteinizing Hormone; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Random Allocation; Testosterone | 1987 |
Monthly implant of luteinizing hormone-releasing hormone agonist: a practical therapeutic approach for sex-steroid dependent gynecologic diseases.
Topics: Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Uterine Neoplasms | 1987 |
Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
Topics: Adult; Buserelin; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Menstruation; Middle Aged; Ovulation; Time Factors; Uterine Neoplasms | 1987 |
Survival of spermatogonial stem cells in the rat after split dose irradiation during LH-RH analogue treatment.
Topics: Animals; Buserelin; Cell Survival; Goserelin; Male; Radiation Dosage; Radiation-Protective Agents; Rats; Spermatogonia; Spermatozoa; Testis | 1987 |
Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
Topics: Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms | 1987 |
Treatment of advanced carcinoma of the prostate by LHRH-agonists.
Topics: Buserelin; Cyproterone; Cyproterone Acetate; Goserelin; Humans; Male; Prostatic Neoplasms; Testosterone | 1987 |
LH-RH analogue treatment of advanced prostatic cancer.
Topics: Buserelin; Goserelin; Humans; Male; Prostatic Neoplasms | 1987 |
Preliminary report on a phase II multicentric study on depot LH-RH analogue in advanced prostatic cancer.
Topics: Buserelin; Drug Evaluation; Goserelin; Humans; Male; Prostatic Neoplasms | 1987 |
Treatment of advanced prostatic cancer with LHRH-analogues. Prevention of "flare-up" phenomenon.
Topics: Buserelin; Goserelin; Humans; Male; Prostatic Neoplasms; Testosterone | 1987 |
The value of reversible androgen suppression as a diagnostic test.
Topics: Androgen Antagonists; Buserelin; Estrogens; Goserelin; Humans; Male; Prostatic Neoplasms | 1987 |
Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue.
Topics: Adult; Buserelin; Creatinine; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Ovary; Pregnanediol; Progesterone | 1987 |
Effective long-term suppression of pituitary-gonadal axis in prostatic cancer by Zoladex (ICI 118,630).
Topics: Buserelin; Delayed-Action Preparations; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Pituitary Gland; Prostatic Neoplasms; Testis; Testosterone; Time Factors | 1987 |
Effects of a gonadotropin-releasing hormone agonist analog (ICI 118630) on endocrine functions of human testis in vivo and in vitro.
Topics: Aged; Buserelin; Chorionic Gonadotropin; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Organ Culture Techniques; Prostatic Neoplasms; Receptors, FSH; Receptors, LH; Testis; Testosterone | 1987 |
Induction of ovulation in anoestrous mares with a slow-release implant of a GnRH analogue (ICI 118 630).
Topics: Anestrus; Animals; Buserelin; Drug Implants; Estrus; Female; Goserelin; Horses; Ovulation Induction; Progesterone Congeners; Trenbolone Acetate | 1987 |
[Treatment of prostatic cancer with monthly injections of an LH-RH analog].
Topics: Aged; Buserelin; Goserelin; Humans; Injections, Subcutaneous; Male; Middle Aged; Prostatic Neoplasms | 1987 |
Renewal timing of long-acting depot luteinizing hormone-releasing hormone agonist (Zoladex) is critical in the treatment of hormone-dependent rat prostatic carcinoma (R3327-H).
Topics: Androgens; Animals; Buserelin; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Goserelin; Kidney; Male; Neoplasms, Hormone-Dependent; Organ Size; Prostate; Prostatic Neoplasms; Rats; Seminal Vesicles; Testis; Testosterone | 1987 |
Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women.
Topics: Adult; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Menstrual Cycle; Progesterone; Reference Values | 1988 |
Phase II study of Zoladex depot in advanced prostatic cancer with special reference to criteria of response and survival.
Topics: Aged; Aged, 80 and over; Buserelin; Castration; Delayed-Action Preparations; Drug Evaluation; Goserelin; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms | 1987 |
Gonadotrophin hormone releasing analogues open new doors in cancer treatment.
Topics: Aged; Aged, 80 and over; Buserelin; Goserelin; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms | 1987 |
Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin.
Topics: Aged; Aged, 80 and over; Androgens; Breast Neoplasms; Buserelin; Estrogens; Female; Gonadotropins, Pituitary; Goserelin; Humans; Menopause; Middle Aged; Ovary | 1988 |
Influence of continuous luteinizing hormone-releasing hormone agonist treatment on steroidogenic enzymes in the human testis.
Topics: Aged; Aged, 80 and over; Buserelin; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Orchiectomy; Prostatic Neoplasms; Testis; Testosterone | 1987 |
Treatment of metastatic prostate carcinoma with the depot LRH analog Zoladex.
Topics: Adult; Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Pain; Prostatic Neoplasms; Ultrasonography | 1988 |
Effects of bovine follicular fluid on gonadotrophin secretion in intact and chronically ovariectomized ewes before and after desensitization of pituitary gonadotrophs to gonadotrophin-releasing hormone.
Topics: Animals; Body Fluids; Buserelin; Cattle; Female; Follicle Stimulating Hormone; Goserelin; Luteinizing Hormone; Ovarian Follicle; Ovariectomy; Pituitary Hormone-Releasing Hormones; Sheep; Time Factors | 1988 |
Effect of LHRH agonist, Zoladex, on ovarian histology.
Topics: Breast Neoplasms; Buserelin; Drug Evaluation; Female; Goserelin; Humans; Menopause; Ovariectomy; Ovary | 1988 |
Mental Health Commission defeated over paedophile.
Topics: Buserelin; Goserelin; Humans; Informed Consent; Male; Mental Health Services; Paraphilic Disorders; Patient Acceptance of Health Care; Pedophilia; United Kingdom | 1988 |
Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer?
Topics: Aged; Buserelin; Diethylstilbestrol; Drug Evaluation; Drug Therapy, Combination; Goserelin; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1988 |
GnRH agonists-antagonists--clinical applications.
Topics: Buserelin; Danazol; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Nafarelin; Osteolysis; Polycystic Ovary Syndrome; Uterine Neoplasms | 1988 |
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Drug Administration Schedule; Goserelin; Humans; Injections, Subcutaneous; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1988 |
Effect of long-acting LHRH analog (Zoladex) on prostate cancer: evaluated by transrectal ultrasonography.
Topics: Aged; Buserelin; Carcinoma; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Ultrasonography | 1988 |
Treatment of advanced prostatic carcinoma with a slow release depot LHRH analogue (Zoladex depot).
Topics: Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Drug Administration Schedule; Estradiol; Estradiol Congeners; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone; Time Factors | 1988 |
Drugs recently released in Belgium: goserelin--ofloxacin.
Topics: Buserelin; Goserelin; Humans; Ofloxacin | 1988 |
Commercially available analogues of GnRH and LH secretion.
Topics: Animals; Buserelin; Female; Gonadotropin-Releasing Hormone; Goserelin; Leuprolide; Luteinizing Hormone; Ovariectomy; Pituitary Gland; Rats; Rats, Inbred Strains | 1988 |
Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation.
Topics: Buserelin; Diethylstilbestrol; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1988 |
Inhibition of rat ovarian [3H]thymidine uptake by luteinizing hormone-releasing hormone agonists: a possible mechanism for preventing damage by cytotoxic agents.
Topics: Animals; Body Weight; Buserelin; Estradiol; Female; Goserelin; Luteinizing Hormone; Organ Size; Ovary; Rats; Rats, Inbred Strains; Thymidine | 1988 |
Treatment of prostatic cancer by monthly injections of an LHRH-analogue depot.
Topics: Aged; Aged, 80 and over; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1988 |
[Therapy with gonadotropin releasing hormone agonists (zoladex) in premenopausal females with metastastic breast cancer].
Topics: Adult; Breast Neoplasms; Buserelin; Female; Follow-Up Studies; Gonadal Steroid Hormones; Goserelin; Humans; Injections, Subcutaneous; Middle Aged; Neoplasm Metastasis | 1988 |
The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist.
Topics: Adult; Buserelin; Epidermal Growth Factor; Estradiol; Female; Goserelin; Humans; Leiomyoma; Menstrual Cycle; Myometrium; Uterine Neoplasms | 1988 |
Rapid rise of serum testosterone following discontinuation of long term treatment of prostate carcinoma with an LHRH-agonist.
Topics: Buserelin; Drug Evaluation; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Substance Withdrawal Syndrome; Testosterone | 1988 |
Long-term results of treating advanced prostatic cancer with the LH-RH analogue Zoladex.
Topics: Buserelin; Follow-Up Studies; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Pain; Prognosis; Prostatic Neoplasms; Testosterone; Time Factors | 1988 |
Clinical study of an LH-RH agonist (ICI 118.630, Zoladex) in the treatment of prostatic cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Buserelin; Carcinoma; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction | 1988 |
LH-RH analogue treatment for advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Follow-Up Studies; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction; Testosterone | 1988 |
Zoladex treatment of symptomatic prostatic carcinoma.
Topics: Buserelin; Carcinoma; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction; Testosterone | 1988 |
Simultaneous administration of a luteinizing hormone releasing hormone agonist and diethylstilbestrol in the initial treatment of prostatic cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Testosterone | 1988 |
Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.
Topics: Aged; Buserelin; Delayed-Action Preparations; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1985 |
A radioimmunoassay for GnRH agonist analogue in serum of patients with prostate cancer treated with D-Ser (tBu)6 AZA Gly10 GnRH.
Topics: Buserelin; Delayed-Action Preparations; Drug Implants; Goserelin; Humans; Infusions, Parenteral; Kinetics; Male; Prostatic Neoplasms; Radioimmunoassay | 1985 |
Biodegradable polymers for the sustained release of peptides.
Topics: Animals; Biodegradation, Environmental; Buserelin; Cell Division; Delayed-Action Preparations; Female; Goserelin; Mammary Neoplasms, Experimental; Peptides; Polymers; Rats | 1985 |
Intratesticular regulation of testosterone secretion: comparison of the effects and interactions of hCG, an LHRH agonist and testicular interstitial fluid on Leydig cell testosterone secretion in vitro.
Topics: Animals; Body Fluids; Buserelin; Cells, Cultured; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Gonadotropin-Releasing Hormone; Goserelin; Kinetics; Leydig Cells; Male; Rats; Rats, Inbred Strains; Testis; Testosterone | 1985 |
Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer.
Topics: Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1985 |
Biodegradable sustained release formulation of the LH-RH analogue 'Zoladex' for the treatment of hormone-responsive tumours.
Topics: Animals; Buserelin; Delayed-Action Preparations; Female; Goserelin; Male; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats | 1985 |
Results obtained in the treatment of prostate cancer patients with Zoladex.
Topics: Buserelin; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1985 |
New treatment for prostatic cancer.
Topics: Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms | 1983 |
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.
Topics: Buserelin; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1984 |
Unresponsiveness of the reproductive organs of the male mouse to treatment with a potent luteinizing hormone-releasing hormone agonist (ICI-118,630).
Topics: Animals; Body Weight; Buserelin; Castration; Genitalia, Male; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Mice; Mice, Nude; Pituitary Gland; Prostate; Testosterone | 1984 |
Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.
Topics: Buserelin; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1984 |
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Topics: Adenocarcinoma; Buserelin; Castration; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1984 |
Experience with an LHRH analogue in the management of relapsed progressive prostatic cancer.
Topics: Acid Phosphatase; Alkaline Phosphatase; Analgesia; Bone Neoplasms; Buserelin; Goserelin; Hormones; Humans; Male; Prostatic Neoplasms | 1984 |
Occult ovarian failure.
Topics: Buserelin; Contraceptives, Oral; Dexamethasone; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Goserelin; Growth Hormone; Growth Substances; Humans; Infertility, Female; Leuprolide; Oocyte Donation; Pregnancy; Primary Ovarian Insufficiency | 1994 |
Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
Topics: Animals; Buserelin; Cell Division; Drug Screening Assays, Antitumor; Gonadotropin-Releasing Hormone; Goserelin; Male; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Tumor Cells, Cultured | 1994 |
Cyclical psoriatic arthritis responding to anti-oestrogen therapy.
Topics: Adult; Arthritis, Psoriatic; Buserelin; Endometrium; Estradiol; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Menstruation; Psoriasis; Tamoxifen; Ultrasonography | 1993 |
Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
Topics: Adult; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Luteinizing Hormone; Triptorelin Pamoate | 1993 |
Resumption of menstruation after amenorrhea in women treated by endometrial ablation and myometrial resection.
Topics: Amenorrhea; Buserelin; Danazol; Electrocoagulation; Endometrium; Female; Follow-Up Studies; Goserelin; Humans; Leuprolide; Menorrhagia; Myometrium; Postoperative Complications; Preoperative Care; Retrospective Studies; Time Factors; Treatment Failure | 1997 |
Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents, Hormonal; Buserelin; Chemotherapy, Adjuvant; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; Infertility, Female; Injections, Intramuscular; Leiomyoma; Leuprolide; Nafarelin; Pregnancy; Pregnancy Rate; Retrospective Studies; Time Factors; Triptorelin Pamoate; Uterine Neoplasms | 1997 |
The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Remodeling; Buserelin; Collagen; Collagen Type I; Endometriosis; Estradiol; Female; Goserelin; Humans; Hydroxyproline; Leiomyoma; Osteocalcin; Peptides; Retrospective Studies | 1998 |
Degradation kinetics of three gonadorelin analogues: developing a method for calculating epimerization parameters.
Topics: Buffers; Buserelin; Chromatography, High Pressure Liquid; Gonadotropin-Releasing Hormone; Goserelin; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Protein Conformation; Temperature; Triptorelin Pamoate | 1998 |
Combined endocrine therapy for breast cancer--new life for an old idea?
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Confounding Factors, Epidemiologic; Disease-Free Survival; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ovary; Premenopause; Randomized Controlled Trials as Topic; Research Design; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome | 2000 |
[The enigma of desmoid fibroma].
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Agents, Hormonal; Buserelin; Child; Child, Preschool; Female; Fibroma, Desmoplastic; Fibromatosis, Aggressive; Follow-Up Studies; Goserelin; Humans; Infant; Male; Middle Aged; Tamoxifen; Treatment Outcome | 2006 |
Quantification of buserelin in a pharmaceutical product by multiple-injection CZE.
Topics: Buserelin; Chromatography, Micellar Electrokinetic Capillary; Coated Materials, Biocompatible; Goserelin; Hexadimethrine Bromide; Injections; Isoelectric Focusing; Mass Spectrometry; Pharmaceutical Preparations; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2007 |
Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles.
Topics: Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Goserelin; Humans; Leuprolide | 2008 |
GnRH receptor and peritoneal plasmin activity.
Topics: Buserelin; Cells, Cultured; Enzyme Activation; Fibrinolysin; Gene Expression; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Peritoneum; Plasminogen Activator Inhibitor 1; Receptors, LHRH; Tissue Plasminogen Activator | 2010 |
Use of collision induced dissociation mass spectrometry as a rapid technique for the identification of pharmacologically active peptides in pharmacopoeial testing.
Topics: Buserelin; Chemistry, Pharmaceutical; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Aspart; Insulin Lispro; Leuprolide; Mass Spectrometry; Models, Chemical; Peptides; Protein Structure, Tertiary; Technology, Pharmaceutical | 2011 |
Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Body Mass Index; Buserelin; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Retrospective Studies; Testosterone; Treatment Outcome | 2012 |
[Role of ovarian suppression in the combined treatment of breast cancer patients in premenopause].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Leuprolide; Middle Aged; Ovary; Perimenopause; Premenopause; Survival Analysis; Treatment Outcome; Triptorelin Pamoate | 2013 |
INN Common stem: -relin.
Topics: Antineoplastic Agents, Hormonal; Buserelin; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Nafarelin; Terminology as Topic; Triptorelin Pamoate | 2017 |
Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries.
Topics: Androgen Antagonists; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate; United States; United States Food and Drug Administration | 2023 |